{
  "meta": {
    "id": "test10",
    "title": "Rheumatology",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "During a temporal artery biopsy for suspected giant cell arteritis, which of the following factors is MOST important for improving diagnostic yield?",
      "options": [
        {
          "label": "A",
          "text": "Obtaining a biopsy sample from the most tender area of the artery",
          "correct": false
        },
        {
          "label": "B",
          "text": "Using a large bore needle for biopsy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Obtaining a biopsy segment of at least 3-5 cm in length",
          "correct": true
        },
        {
          "label": "D",
          "text": "Performing the biopsy under general anesthesia",
          "correct": false
        }
      ],
      "correct_answer": "C. Obtaining a biopsy segment of at least 3-5 cm in length",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Obtaining a biopsy segment of at least 3-5 cm in length</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Obtaining a biopsy sample from the most tender area of the artery: While tenderness might indicate inflammation, a longer segment is more important for sampling.</li><li>\u2022 Option A. Obtaining a biopsy sample from the most tender area of the artery:</li><li>\u2022 Option B. Using a large bore needle for biopsy: The needle size is less relevant than the length of the biopsy specimen.</li><li>\u2022 Option B. Using a large bore needle for biopsy:</li><li>\u2022 Option D. Performing the biopsy under general anesthesia: General anesthesia is not typically required.</li><li>\u2022 Option D. Performing the biopsy under general anesthesia:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Adequate biopsy length is essential for accurate diagnosis of GCA. While other factors like tenderness or imaging findings can guide the biopsy site, the length of the specimen is the most critical determinant of diagnostic yield.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0b769f12",
      "audio": ""
    },
    {
      "text": "A 70-year-old woman presents with a 2-week history of headaches, jaw claudication, and scalp tenderness. She has been taking low-dose prednisone for polymyalgia rheumatica (PMR) for the past 5 days. Which of the following is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Discontinue prednisone and observe for symptom resolution",
          "correct": false
        },
        {
          "label": "B",
          "text": "Order a temporal artery ultrasound",
          "correct": false
        },
        {
          "label": "C",
          "text": "Perform a temporal artery biopsy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Increase the dose of prednisone",
          "correct": false
        }
      ],
      "correct_answer": "C. Perform a temporal artery biopsy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Perform a temporal artery biopsy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Discontinue prednisone and observe for symptom resolution: While low-dose prednisone may be used to manage polymyalgia rheumatica (PMR), it's not sufficient to treat giant cell arteritis (GCA). Discontinuing it without a definitive diagnosis could lead to worsening symptoms and potentially irreversible vision loss.</li><li>\u2022 Option A. Discontinue prednisone and observe for symptom resolution:</li><li>\u2022 Option B. Order a temporal artery ultrasound: While ultrasound can be a helpful tool in the assessment of GCA, it is not as definitive as a biopsy. A negative ultrasound doesn't rule out GCA, and a positive result still requires biopsy confirmation.</li><li>\u2022 Option B. Order a temporal artery ultrasound:</li><li>\u2022 Option D. Increase the dose of prednisone: Increasing the dose of prednisone without a biopsy-confirmed diagnosis of GCA is not recommended. Higher doses of prednisone carry a significant risk of side effects, and it's important to establish the diagnosis first to determine the appropriate treatment course.</li><li>\u2022 Option D. Increase the dose of prednisone:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Early diagnosis and treatment of GCA are crucial to prevent complications like vision loss. Even if a patient is already on glucocorticoids, a biopsy should not be delayed, as it is the gold standard for confirming the diagnosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e809ac57",
      "audio": ""
    },
    {
      "text": "A 65-year-old woman with newly diagnosed temporal arteritis complains of blurred vision in one eye. Which of the following is the most appropriate immediate intervention?",
      "options": [
        {
          "label": "A",
          "text": "Continue with oral prednisone 40 mg daily",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase the dose of oral prednisone to 60 mg daily",
          "correct": false
        },
        {
          "label": "C",
          "text": "Administer intravenous methylprednisolone 1000 mg daily for 3 days",
          "correct": true
        },
        {
          "label": "D",
          "text": "Refer urgently to ophthalmology for assessment",
          "correct": false
        }
      ],
      "correct_answer": "C. Administer intravenous methylprednisolone 1000 mg daily for 3 days",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Administer intravenous methylprednisolone 1000 mg daily for 3 days</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Continue with oral prednisone 40 mg daily: Oral prednisone is the standard treatment for temporal arteritis, but higher doses or IV steroids are needed for ocular involvement.</li><li>\u2022 Option A. Continue with oral prednisone 40 mg daily:</li><li>\u2022 Option D. Refer urgently to ophthalmology for assessment: Ophthalmology referral is essential, but not the immediate first step</li><li>\u2022 Option D. Refer urgently to ophthalmology for assessment:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Prompt recognition and treatment of visual symptoms in temporal arteritis are critical to preserve vision. High-dose intravenous glucocorticoids are the mainstay of initial therapy for ocular involvement.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fbb6c6ac",
      "audio": ""
    },
    {
      "text": "A 70-year-old woman presents with new-onset headache, jaw claudication, and scalp tenderness. Her erythrocyte sedimentation rate (ESR) is elevated. Which of the following medications is FDA approved for the treatment of giant cell arteritis (GCA)?",
      "options": [
        {
          "label": "A",
          "text": "Methotrexate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rituximab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tocilizumab",
          "correct": true
        },
        {
          "label": "D",
          "text": "Infliximab",
          "correct": false
        }
      ],
      "correct_answer": "C. Tocilizumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Tocilizumab</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Methotrexate and Option B. Rituximab are not FDA-approved for GCA.</li><li>\u2022 Option A. Methotrexate</li><li>\u2022 Option B. Rituximab</li><li>\u2022 Option D. Infliximab is a TNF inhibitor and is not used in GCA.</li><li>\u2022 Option D. Infliximab</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 While glucocorticoids remain the first-line treatment for GCA, tocilizumab is an important alternative for patients who cannot tolerate glucocorticoids or who experience relapses despite glucocorticoid therapy. It is essential to be aware of the available treatment options for GCA to provide optimal care for patients.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c67cc785",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman presents with fatigue, weight loss, and claudication in her arms and legs. Physical exam reveals diminished pulses in the upper extremities and a carotid bruit. Which of the following imaging modalities is the GOLD STANDARD for confirming the diagnosis of Takayasu arteritis?",
      "options": [
        {
          "label": "A",
          "text": "Chest X-ray",
          "correct": false
        },
        {
          "label": "B",
          "text": "Doppler ultrasound of the carotid arteries",
          "correct": false
        },
        {
          "label": "C",
          "text": "Contrast-enhanced CT angiography",
          "correct": true
        },
        {
          "label": "D",
          "text": "Magnetic resonance angiography (MRA)",
          "correct": false
        }
      ],
      "correct_answer": "C. Contrast-enhanced CT angiography",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Contrast-enhanced CT angiography</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Chest X-ray: Chest X-ray is not sensitive enough to detect early vascular changes.</li><li>\u2022 Option A. Chest X-ray:</li><li>\u2022 Option B. Doppler ultrasound of the carotid arteries: Doppler ultrasound can assess blood flow but is limited in visualizing the arterial wall in detail.</li><li>\u2022 Option B. Doppler ultrasound of the carotid arteries:</li><li>\u2022 Option D. Magnetic resonance angiography (MRA): MRA is a good alternative to CT angiography, but CT is often more readily available.</li><li>\u2022 Option D. Magnetic resonance angiography (MRA):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the gold standard imaging modality for TAK is essential for timely diagnosis and appropriate management. While other imaging modalities can provide supportive evidence, CT angiography remains the most definitive diagnostic tool.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5a76250d",
      "audio": ""
    },
    {
      "text": "A 28-year-old Asian woman presents with fatigue, weight loss, and arm claudication. Physical exam reveals a blood pressure discrepancy between arms and diminished brachial pulses. Which of the following diagnoses is most likely?",
      "options": [
        {
          "label": "A",
          "text": "Giant cell arteritis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Polyarteritis nodosa",
          "correct": false
        },
        {
          "label": "C",
          "text": "Kawasaki disease",
          "correct": false
        },
        {
          "label": "D",
          "text": "Takayasu arteritis",
          "correct": true
        }
      ],
      "correct_answer": "D. Takayasu arteritis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Takayasu arteritis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Giant cell arteritis: Typically affects older individuals and involves cranial arteries.</li><li>\u2022 Option A. Giant cell arteritis:</li><li>\u2022 Option B. Polyarteritis nodosa: Affects medium-sized arteries and presents with multisystem involvement.</li><li>\u2022 Option B. Polyarteritis nodosa:</li><li>\u2022 Option C. Kawasaki disease: Kawasaki disease is a childhood vasculitis.</li><li>\u2022 Option C. Kawasaki disease:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Takayasu arteritis is a large vessel vasculitis that predominantly affects young women, particularly those of Asian descent. It is important to consider this diagnosis in patients presenting with characteristic clinical features and to initiate prompt evaluation and treatment to prevent complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a33bf41b",
      "audio": ""
    },
    {
      "text": "A 45-year-old man with a history of hepatitis B presents with fever, weight loss, and abdominal pain. He also complains of new-onset muscle weakness and skin nodules. Which of the following diagnostic tests would have the HIGHEST diagnostic yield for polyarteritis nodosa (PAN)?",
      "options": [
        {
          "label": "A",
          "text": "Antineutrophil cytoplasmic antibody (ANCA) testing",
          "correct": false
        },
        {
          "label": "B",
          "text": "Biopsy of a skin nodule",
          "correct": true
        },
        {
          "label": "C",
          "text": "Abdominal ultrasound",
          "correct": false
        },
        {
          "label": "D",
          "text": "Electromyography (EMG)",
          "correct": false
        }
      ],
      "correct_answer": "B. Biopsy of a skin nodule",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Biopsy of a skin nodule</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Antineutrophil cytoplasmic antibody (ANCA) testing: ANCA is usually negative in PAN.</li><li>\u2022 Option A.</li><li>\u2022 Antineutrophil cytoplasmic antibody (ANCA) testing:</li><li>\u2022 Option C. Abdominal ultrasound: Ultrasound might show organ ischemia, but not the underlying vasculitis.</li><li>\u2022 Option C. Abdominal ultrasound:</li><li>\u2022 Option D. Electromyography (EMG): EMG can assess muscle involvement but is not diagnostic</li><li>\u2022 Option D. Electromyography (EMG):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 When suspecting PAN, a tissue biopsy of an affected organ (such as skin, nerve, or muscle) is the most reliable diagnostic test. While other tests can provide supportive evidence, biopsy provides definitive proof of vasculitis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6d0c7665",
      "audio": ""
    },
    {
      "text": "A 50-year-old man with a recent diagnosis of polyarteritis nodosa (PAN) is most likely to present with which of the following renal manifestations?",
      "options": [
        {
          "label": "A",
          "text": "Nephrotic syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rapidly progressive glomerulonephritis (RPGN)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Renal failure and hypertension",
          "correct": true
        },
        {
          "label": "D",
          "text": "Nephrolithiasis",
          "correct": false
        }
      ],
      "correct_answer": "C. Renal failure and hypertension",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Renal failure and hypertension</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Nephrotic syndrome : This is characterized by heavy proteinuria, hypoalbuminemia, edema, and hyperlipidemia. It's not the typical presentation of renal involvement in PAN.</li><li>\u2022 Option A. Nephrotic syndrome</li><li>\u2022 Option B. Rapidly progressive glomerulonephritis (RPGN): While RPGN can cause renal failure, it's less common in PAN and usually associated with other vasculitides like microscopic polyangiitis or granulomatosis with polyangiitis.</li><li>\u2022 Option B. Rapidly progressive glomerulonephritis (RPGN):</li><li>\u2022 Option D. Nephrolithiasis (Kidney Stones): Kidney stones are not directly related to the vasculitic process of PAN</li><li>\u2022 Option D. Nephrolithiasis (Kidney Stones):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 PAN commonly affects the kidneys, leading to hypertension and renal failure. Recognizing this association is crucial for early diagnosis and appropriate management to prevent irreversible kidney damage.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "72608f75",
      "audio": ""
    },
    {
      "text": "A 3-year-old child presents with a 5-day history of high fever, bilateral conjunctivitis, erythema of the oral mucosa and lips, and cervical lymphadenopathy. The child\u2019s tongue is shown below. Which of the following diagnoses is most likely?",
      "options": [
        {
          "label": "A",
          "text": "Scarlet fever",
          "correct": false
        },
        {
          "label": "B",
          "text": "Measles",
          "correct": false
        },
        {
          "label": "C",
          "text": "Kawasaki disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Infectious mononucleosis",
          "correct": false
        }
      ],
      "correct_answer": "C. Kawasaki disease",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/29/screenshot-2024-07-29-174133.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Kawasaki disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Scarlet fever typically presents with a sandpaper-like rash and sore throat.</li><li>\u2022 Option A. Scarlet fever</li><li>\u2022 Option B. Measles has a characteristic maculopapular rash and Koplik spots in the mouth.</li><li>\u2022 Option B. Measles</li><li>\u2022 Option D. Infectious mononucleosis is associated with fatigue, lymphadenopathy, and atypical lymphocytes.</li><li>\u2022 Option D. Infectious mononucleosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the characteristic clinical features of Kawasaki disease is crucial for timely diagnosis and treatment to prevent complications, such as coronary artery aneurysms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "29a7584a",
      "audio": ""
    },
    {
      "text": "A 4-year-old child with Kawasaki disease is found to have coronary artery aneurysms on echocardiogram. Which of the following histopathological findings would most likely be present in the affected coronary arteries?",
      "options": [
        {
          "label": "A",
          "text": "Granulomatous inflammation with giant cells",
          "correct": false
        },
        {
          "label": "B",
          "text": "Transmural inflammation with fibrinoid necrosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Intimal proliferation and infiltration of mononuclear cells",
          "correct": true
        },
        {
          "label": "D",
          "text": "Medial calcification and fibrosis",
          "correct": false
        }
      ],
      "correct_answer": "C. Intimal proliferation and infiltration of mononuclear cells",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Intimal proliferation and infiltration of mononuclear cells</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Granulomatous inflammation with giant cells: Granulomatous inflammation is seen in conditions like giant cell arteritis.</li><li>\u2022 Option A. Granulomatous inflammation with giant cells:</li><li>\u2022 Option B. Transmural inflammation with fibrinoid necrosis: Transmural inflammation with fibrinoid necrosis is seen in polyarteritis nodosa.</li><li>\u2022 Option B. Transmural inflammation with fibrinoid necrosis:</li><li>\u2022 Option D. Medial calcification and fibrosis: Medial calcification and fibrosis are more typical of atherosclerosis.</li><li>\u2022 Option D. Medial calcification and fibrosis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understanding the pathological changes in coronary arteries caused by Kawasaki disease is important for recognizing the potential for long-term cardiovascular complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a1bd6a1e",
      "audio": ""
    },
    {
      "text": "A 7-year-old boy with a history of Kawasaki disease presents with chest pain and signs of myocardial ischemia. Echocardiogram reveals giant coronary artery aneurysms with evidence of thrombosis. Which of the following surgical interventions is MOST likely to be considered for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Coronary artery stenting",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pericardiectomy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thromboendarterectomy and aneurysmal reconstruction",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cardiac transplantation",
          "correct": false
        }
      ],
      "correct_answer": "C. Thromboendarterectomy and aneurysmal reconstruction",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Thromboendarterectomy and aneurysmal reconstruction</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Coronary artery stenting: Stenting is less suitable for giant aneurysms.</li><li>\u2022 Option A. Coronary artery stenting:</li><li>\u2022 Option B. Pericardiectomy: Pericardiectomy is the removal of the pericardium and is not relevant to coronary artery disease.</li><li>\u2022 Option B. Pericardiectomy:</li><li>\u2022 Option D. Cardiac transplantation: Cardiac transplantation is a last resort for severe, refractory cases.</li><li>\u2022 Option D. Cardiac transplantation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Timely surgical intervention is crucial for managing giant coronary artery aneurysms in Kawasaki disease to prevent life-threatening complications like myocardial infarction and sudden cardiac death.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "87023bb3",
      "audio": ""
    },
    {
      "text": "A 3-year-old boy presents with fever, rash, conjunctival injection, and swollen glands, raising suspicion for Kawasaki disease. What is the most likely initial dose of aspirin that would be prescribed by the doctor?",
      "options": [
        {
          "label": "A",
          "text": "10 mg/kg/day",
          "correct": false
        },
        {
          "label": "B",
          "text": "20 mg/kg/day",
          "correct": false
        },
        {
          "label": "C",
          "text": "50 mg/kg/day",
          "correct": false
        },
        {
          "label": "D",
          "text": "80-100 mg/kg/day",
          "correct": true
        }
      ],
      "correct_answer": "D. 80-100 mg/kg/day",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 80-100 mg/kg/day</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. 10 mg/kg/day: This is a low dose of aspirin and would not be sufficient for the anti-inflammatory effect needed in acute Kawasaki disease.</li><li>\u2022 Option A. 10 mg/kg/day:</li><li>\u2022 Option B. 20 mg/kg/day: This dose is also too low for the initial treatment of Kawasaki disease.</li><li>\u2022 Option B. 20 mg/kg/day:</li><li>\u2022 Option C. 50 mg/kg/day: This dose may be appropriate for some children, but the standard initial dose is generally higher.</li><li>\u2022 Option C. 50 mg/kg/day:</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 High-dose aspirin (80-100 mg/kg/day) is the standard initial treatment for Kawasaki disease due to its anti-inflammatory and antipyretic (fever-reducing) effects. This higher dose is crucial during the acute phase of the illness to control inflammation and potentially reduce the risk of coronary artery complications. Once the fever subsides, the aspirin dose is typically tapered down to a lower dose (3-5 mg/kg/day) for its antiplatelet effect.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "34d5aad0",
      "audio": ""
    },
    {
      "text": "A patient with a history of recurrent sinusitis and chronic cough now presents with bloody nasal discharge and a new saddle nose deformity. Which additional finding would MOST strongly support a diagnosis of granulomatosis with polyangiitis (GPA)?",
      "options": [
        {
          "label": "A",
          "text": "Positive rheumatoid factor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated antinuclear antibody (ANA) titer",
          "correct": false
        },
        {
          "label": "C",
          "text": "Positive cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Eosinophilia on complete blood count (CBC)",
          "correct": false
        }
      ],
      "correct_answer": "C. Positive cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Positive cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Positive rheumatoid factor and Option B. Elevated antinuclear antibody (ANA) titer are not specific for GPA.</li><li>\u2022 Option A. Positive rheumatoid factor</li><li>\u2022 Option B. Elevated antinuclear antibody (ANA) titer are</li><li>\u2022 Option D. Eosinophilia on complete blood count (CBC): Eosinophilia is more characteristic of eosinophilic granulomatosis with polyangiitis (EGPA).</li><li>\u2022 Option D. Eosinophilia on complete blood count (CBC):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the significance of c-ANCA positivity in the context of suspected GPA is crucial for early diagnosis and prompt initiation of treatment to prevent irreversible organ damage.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "477a8c6c",
      "audio": ""
    },
    {
      "text": "Which of the following statements about renal involvement in GPA is FALSE?",
      "options": [
        {
          "label": "A",
          "text": "It is the most common cause of mortality in untreated GPA",
          "correct": false
        },
        {
          "label": "B",
          "text": "It typically presents with rapidly progressive renal failure",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is often associated with pulmonary hemorrhage",
          "correct": true
        },
        {
          "label": "D",
          "text": "It can be effectively treated with immunosuppressive therapy",
          "correct": false
        }
      ],
      "correct_answer": "C. It is often associated with pulmonary hemorrhage",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) It is often associated with pulmonary hemorrhage.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 The other statements are true regarding renal involvement in GPA.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understanding the patterns of organ involvement in GPA is important for accurate diagnosis and management. While renal involvement is a serious complication, it is not typically associated with pulmonary hemorrhage.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "49b48ed1",
      "audio": ""
    },
    {
      "text": "A patient with GPA presents with rapidly progressive glomerulonephritis and diffuse alveolar hemorrhage. Which of the following is the most appropriate initial treatment?",
      "options": [
        {
          "label": "A",
          "text": "Oral prednisone 1 mg/kg/day",
          "correct": false
        },
        {
          "label": "B",
          "text": "Methotrexate 25 mg/week",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rituximab 375 mg/m2 weekly for 4 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "Intravenous methylprednisolone 1000 mg daily for 3 days",
          "correct": true
        }
      ],
      "correct_answer": "D. Intravenous methylprednisolone 1000 mg daily for 3 days",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Intravenous methylprednisolone 1000 mg daily for 3 days</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Oral prednisone 1 mg/kg/day: Oral prednisone is too slow and less potent for this scenario.</li><li>\u2022 Option A. Oral prednisone 1 mg/kg/day:</li><li>\u2022 Option B. Methotrexate 25 mg/week: Methotrexate is a DMARD and not appropriate for acute life-threatening disease.</li><li>\u2022 Option B. Methotrexate 25 mg/week:</li><li>\u2022 Option C. Rituximab 375 mg/m2 weekly for 4 weeks: Rituximab is an option, but high-dose glucocorticoids are typically used first.</li><li>\u2022 Option C. Rituximab 375 mg/m2 weekly for 4 weeks:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the need for rapid intervention with high-dose glucocorticoids in patients with life-threatening manifestations of GPA is essential for optimal management and improved outcomes. Early diagnosis and aggressive treatment can significantly reduce morbidity and mortality associated with this disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "097eed2b",
      "audio": ""
    },
    {
      "text": "A patient presents with asthma, eosinophilia, and a skin biopsy revealing a necrotizing vasculitis with extravascular granulomas. Which of the following histopathological findings is most characteristic of EGPA?",
      "options": [
        {
          "label": "A",
          "text": "Leukocytoclastic vasculitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fibrinoid necrosis without granulomas",
          "correct": false
        },
        {
          "label": "C",
          "text": "Granulomas with eosinophilic infiltration",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lymphocytic vasculitis",
          "correct": false
        }
      ],
      "correct_answer": "C. Granulomas with eosinophilic infiltration",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Granulomas with eosinophilic infiltration</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Leukocytoclastic vasculitis: This type of vasculitis is characterized by the fragmentation of neutrophils (leukocytoclasis) in small blood vessel walls. While it can be seen in EGPA, it is not specific and can occur in other vasculitides as well.</li><li>\u2022 Option A. Leukocytoclastic vasculitis:</li><li>\u2022 Option B. Fibrinoid necrosis without granulomas: Fibrinoid necrosis, a type of tissue damage, is often present in various vasculitides, including EGPA. However, the absence of granulomas makes this finding less specific for EGPA.</li><li>\u2022 Option B. Fibrinoid necrosis without granulomas:</li><li>\u2022 Option D. Lymphocytic vasculitis: This refers to vasculitis with predominantly lymphocytic infiltration. While lymphocytes may be present in EGPA lesions, the predominance of eosinophils and the presence of granulomas are more characteristic features.</li><li>\u2022 Option D. Lymphocytic vasculitis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the unique histological pattern of granulomas with eosinophils is crucial for diagnosing EGPA. This finding, combined with clinical and serological evidence, can confirm the diagnosis and guide treatment decisions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "357f6cdd",
      "audio": ""
    },
    {
      "text": "Eosinophilic granulomatosis with polyangiitis (EGPA) can affect multiple organ systems. What is the approximate percentage of EGPA patients who experience mononeuritis multiplex (MM), the second most common manifestation of this disease?",
      "options": [
        {
          "label": "A",
          "text": "25%",
          "correct": false
        },
        {
          "label": "B",
          "text": "55%",
          "correct": false
        },
        {
          "label": "C",
          "text": "63%",
          "correct": false
        },
        {
          "label": "D",
          "text": "72%",
          "correct": true
        }
      ],
      "correct_answer": "D. 72%",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 72%</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Understanding the prevalence of MM in EGPA is essential for recognizing potential neurological complications and initiating appropriate management. Early diagnosis and treatment can prevent irreversible nerve damage.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f585c4c",
      "audio": ""
    },
    {
      "text": "A 45-year-old man with a history of asthma and eosinophilia presents with new-onset shortness of breath, chest pain, and fatigue. He has recently been diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA). An echocardiogram reveals significant LV dysfunction and evidence of myocarditis. Which of the following treatment regimens is most appropriate for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Oral prednisone alone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Methotrexate and prednisone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cyclophosphamide and prednisone",
          "correct": true
        },
        {
          "label": "D",
          "text": "Rituximab and prednisone",
          "correct": false
        }
      ],
      "correct_answer": "C. Cyclophosphamide and prednisone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Cyclophosphamide and prednisone</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Oral prednisone alone: Oral prednisone alone is insufficient for severe disease.</li><li>\u2022 Option A. Oral prednisone alone:</li><li>\u2022 Option B. Methotrexate and prednisone: Methotrexate is less potent than cyclophosphamide.</li><li>\u2022 Option B. Methotrexate and prednisone:</li><li>\u2022 Option D. Rituximab and prednisone: Rituximab is an option for refractory disease or in those who cannot tolerate cyclophosphamide.</li><li>\u2022 Option D. Rituximab and prednisone:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Severe EGPA, especially with cardiac involvement, requires aggressive treatment to achieve remission and prevent complications. Cyclophosphamide and prednisone are the mainstay of initial therapy, but other immunosuppressive agents like rituximab may be considered in refractory cases or when cyclophosphamide is contraindicated.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1b1faa7",
      "audio": ""
    },
    {
      "text": "A 48-year-old woman presents with a purpuric rash, hematuria, and hemoptysis. Renal biopsy reveals a pauci-immune necrotizing crescentic glomerulonephritis. Which of the following serological markers is MOST likely to be positive in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Anti-glomerular basement membrane (GBM) antibodies",
          "correct": false
        },
        {
          "label": "B",
          "text": "Antinuclear antibodies (ANA)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Anti-proteinase 3 (PR3) antibodies",
          "correct": false
        }
      ],
      "correct_answer": "C. Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Anti- Glomerular Basement Membrane (GBM) antibodies: These are characteristic of Goodpasture syndrome, which usually presents with pulmonary hemorrhage and rapidly progressive glomerulonephritis.</li><li>\u2022 Option A. Anti- Glomerular Basement Membrane (GBM) antibodies:</li><li>\u2022 Option B. Antinuclear antibodies (ANA): While ANA can be positive in some vasculitides, it is not specific for MPA.</li><li>\u2022 Option B. Antinuclear antibodies (ANA):</li><li>\u2022 Option D. Anti- Proteinase 3(PR3) antibodies: These are cytoplasmic ANCA (c-ANCA) and are more specific for granulomatosis with polyangiitis (GPA).</li><li>\u2022 Option D. Anti-</li><li>\u2022 Proteinase 3(PR3) antibodies:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Microscopic polyangiitis (MPA) is a small vessel vasculitis characterized by kidney inflammation, lung involvement, skin involvement, and possible involvement of other organs.Testing p-ANCA, especially against myeloperoxidase (MPO), is a key diagnostic marker for MPA, found in about 70% of patients.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "35d5558f",
      "audio": ""
    },
    {
      "text": "A 4-year-old child presents with a purpuric rash on the lower extremities and buttocks, abdominal pain, and joint swelling. Which of the following diagnostic approaches would be MOST helpful in confirming a diagnosis of IgA vasculitis (Henoch-Sch\u00f6nlein purpura)?",
      "options": [
        {
          "label": "A",
          "text": "Antinuclear antibody (ANA) testing",
          "correct": false
        },
        {
          "label": "B",
          "text": "Serum IgA levels",
          "correct": false
        },
        {
          "label": "C",
          "text": "Skin biopsy with immunofluorescence",
          "correct": true
        },
        {
          "label": "D",
          "text": "Abdominal ultrasound",
          "correct": false
        }
      ],
      "correct_answer": "C. Skin biopsy with immunofluorescence",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Skin biopsy with immunofluorescence</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Antinuclear antibody (ANA) testing: ANA is typically negative in IgA vasculitis, and a positive result would suggest a different autoimmune condition.</li><li>\u2022 Option A.</li><li>\u2022 Antinuclear antibody (ANA) testing:</li><li>\u2022 Option B. Serum IgA levels: While IgA levels may be elevated in IgA vasculitis, they are not specific for the disease and can be elevated in other conditions.</li><li>\u2022 Option B. Serum IgA levels:</li><li>\u2022 Option D. Abdominal ultrasound: Abdominal ultrasound can help assess for gastrointestinal complications (e.g., intussusception) in IgA vasculitis, but it does not confirm the diagnosis.</li><li>\u2022 Option D. Abdominal ultrasound:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 While other tests may provide supportive evidence, a skin biopsy with immunofluorescence remains the gold standard for definitive diagnosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ebded770",
      "audio": ""
    },
    {
      "text": "A 55-year-old man with a history of Hepatitis C presents with fatigue, arthralgia, palpable purpura on the lower extremities, and peripheral neuropathy. Laboratory tests reveal elevated rheumatoid factor and low complement levels. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Type I cryoglobulinemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Type II cryoglobulinemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Type III cryoglobulinemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Type IV cryoglobulinemia",
          "correct": false
        }
      ],
      "correct_answer": "B. Type II cryoglobulinemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Type II cryoglobulinemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Type I cryoglobulinemia : Type I is associated with lymphoproliferative disorders.</li><li>\u2022 Option A. Type I cryoglobulinemia</li><li>\u2022 Option C. Type III cryoglobulinemia: Type III is associated with autoimmune diseases.</li><li>\u2022 Option C. Type III cryoglobulinemia:</li><li>\u2022 Option D. Type IV cryoglobulinemia : There is no type IV cryoglobulinemia.</li><li>\u2022 Option D. Type IV cryoglobulinemia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the association between Hepatitis C and type II cryoglobulinemia is crucial for accurate diagnosis and management of cryoglobulinemic vasculitis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a7302900",
      "audio": ""
    },
    {
      "text": "A patient with hepatitis C-associated cryoglobulinemic vasculitis has achieved sustained virologic response (SVR) after antiviral therapy. Which of the following is the most likely outcome regarding their vasculitis?",
      "options": [
        {
          "label": "A",
          "text": "No improvement in vasculitis activity",
          "correct": false
        },
        {
          "label": "B",
          "text": "Worsening of vasculitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Complete resolution of vasculitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Partial improvement with decreased cryoglobulin levels",
          "correct": true
        }
      ],
      "correct_answer": "D. Partial improvement with decreased cryoglobulin levels",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Partial improvement with decreased cryoglobulin levels</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. No improvement in vasculitis activity: Achieving SVR often leads to significant improvement in symptoms and reduction of cryoglobulin levels.</li><li>\u2022 Option A. No improvement in vasculitis activity:</li><li>\u2022 Option B. Worsening of vasculitis: While rare, there have been some cases where antiviral therapy can lead to a temporary worsening of vasculitis followed by improvement, and overall, antiviral therapy is expected to be beneficial.</li><li>\u2022 Option B. Worsening of vasculitis:</li><li>\u2022 Option C. Complete resolution of vasculitis: While SVR often leads to significant improvement in vasculitis, complete resolution may not always occur.</li><li>\u2022 Option C. Complete resolution of vasculitis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Antiviral therapy is essential for managing hepatitis C-associated cryoglobulinemic vasculitis. While SVR is associated with improved outcomes, patients may still require additional immunosuppressive therapy or other interventions to achieve complete remission of vasculitis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9f01dcd4",
      "audio": ""
    },
    {
      "text": "A 34-year-old woman presents with recurrent, long-lasting wheals on her trunk and limbs, accompanied by joint pain and abdominal discomfort. The lesions often leave a bruise-like mark. Laboratory tests reveal normal C3 and C4 complement levels. Which of the following autoantibodies is most likely to be elevated in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Anti-nuclear antibody (ANA)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti-double stranded DNA (anti-dsDNA) antibody",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-C1q antibody",
          "correct": true
        },
        {
          "label": "D",
          "text": "Antineutrophil cytoplasmic antibody (ANCA)",
          "correct": false
        }
      ],
      "correct_answer": "C. Anti-C1q antibody",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Anti-C1q antibody</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Anti-nuclear antibody (ANA): While ANA can be positive in some cases of HUV, it is not specific and can be found in other autoimmune diseases.</li><li>\u2022 Option A. Anti-nuclear antibody (ANA):</li><li>\u2022 Option B. Anti- double stranded DNA (dsDNA) antibody: This antibody is more specific for systemic lupus erythematosus (SLE).</li><li>\u2022 Option B. Anti-</li><li>\u2022 double stranded DNA (dsDNA) antibody:</li><li>\u2022 Option D. Antineutrophil cytoplasmic antibody (ANCA): ANCA is associated with other vasculitides, like granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA), not urticarial vasculitis.</li><li>\u2022 Option D.</li><li>\u2022 Antineutrophil cytoplasmic antibody (ANCA):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Hypocomplementemic Urticarial Vasculitis (HUV):</li><li>\u27a4 Characterized by urticarial lesions lasting >24 hours, leaving bruise-like marks, and systemic symptoms like joint pain and abdominal discomfort. Laboratory findings may show low complement levels, but normal C3 and C4 levels can occur. Anti-C1q antibodies are highly associated with HUV and considered a diagnostic marker.</li><li>\u27a4 Characterized by urticarial lesions lasting >24 hours, leaving bruise-like marks, and systemic symptoms like joint pain and abdominal discomfort.</li><li>\u27a4 Laboratory findings may show low complement levels, but normal C3 and C4 levels can occur.</li><li>\u27a4 Anti-C1q antibodies are highly associated with HUV and considered a diagnostic marker.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "50ab36d0",
      "audio": ""
    },
    {
      "text": "A 25-year-old male presents with recurrent painful oral and genital ulcers. He also has a history of erythema nodosum. Which of the following tests is most likely to be positive and aid in the diagnosis of Beh\u00e7et syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Pathergy test",
          "correct": true
        },
        {
          "label": "B",
          "text": "Anti-nuclear antibody (ANA) test",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rheumatoid factor (RF) test",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anti-neutrophil cytoplasmic antibody (ANCA) test",
          "correct": false
        }
      ],
      "correct_answer": "A. Pathergy test",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Pathergy test</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Anti-nuclear antibody (ANA) , Option C. Rheumatoid factor (RF) , and Option D. Anti-neutrophil cytoplasmic antibody (ANCA) tests are not specific for Beh\u00e7et's and are more commonly associated with other autoimmune diseases.</li><li>\u2022 Option B. Anti-nuclear antibody (ANA)</li><li>\u2022 Option C. Rheumatoid factor (RF)</li><li>\u2022 Option D. Anti-neutrophil cytoplasmic antibody (ANCA)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the utility of the pathergy test is essential in the diagnosis of Beh\u00e7et disease. While it is not pathognomonic, a positive pathergy test, along with the characteristic clinical manifestations, can strongly support the diagnosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "890e92c8",
      "audio": ""
    },
    {
      "text": "A 32-year-old man of Turkish descent presents with recurrent oral ulcers, genital ulcers, and uveitis. You suspect Beh\u00e7et disease. Which of the following statements regarding HLA-B*51 testing in this patient is MOST accurate?",
      "options": [
        {
          "label": "A",
          "text": "HLA-B51 testing is the gold standard for diagnosing Beh\u00e7et disease.",
          "correct": false
        },
        {
          "label": "B",
          "text": "A positive HLA-B51 test confirms the diagnosis of Beh\u00e7et disease.",
          "correct": false
        },
        {
          "label": "C",
          "text": "A negative HLA-B51 test rules out the diagnosis of Beh\u00e7et disease.",
          "correct": false
        },
        {
          "label": "D",
          "text": "HLA-B51 testing can be helpful, but it's not definitive for diagnosis due to its prevalence in the general population.",
          "correct": true
        }
      ],
      "correct_answer": "D. HLA-B51 testing can be helpful, but it's not definitive for diagnosis due to its prevalence in the general population.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) HLA-B*51 testing can be helpful, but it's not definitive for diagnosis due to its prevalence in the general population.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Options A. HLA-B51 testing is the gold standard for diagnosing Beh\u00e7et disease and B. A positive HLA-B51 test confirms the diagnosis of Beh\u00e7et disease: HLA-B*51 testing is not the gold standard for diagnosis and does not confirm the diagnosis on its own.</li><li>\u2022 Options A.</li><li>\u2022 HLA-B51 testing is the gold standard for diagnosing Beh\u00e7et disease</li><li>\u2022 B. A positive HLA-B51 test confirms the diagnosis of Beh\u00e7et disease:</li><li>\u2022 Option C. A negative HLA-B51 test rules out the diagnosis of Beh\u00e7et disease: A negative HLA-B51 test does not exclude the diagnosis of Beh\u00e7et disease, as some patients with the disease are HLA-B51 negative.</li><li>\u2022 Option C. A negative HLA-B51 test rules out the diagnosis of Beh\u00e7et disease:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 HLA-B*51 testing should be interpreted with caution and in the context of the overall clinical picture. A positive test can increase suspicion for Beh\u00e7et disease, but it does not confirm or rule out the diagnosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ab0986d1",
      "audio": ""
    },
    {
      "text": "A 38-year-old woman with Beh\u00e7et syndrome presents with recurrent, painful oral ulcers that have not responded to topical corticosteroids. She has no significant comorbidities. Which of the following medications is FDA-approved for the treatment of oral ulcers in Beh\u00e7et syndrome and would be the most appropriate next step in management?",
      "options": [
        {
          "label": "A",
          "text": "Colchicine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Azathioprine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Apremilast",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cyclophosphamide",
          "correct": false
        }
      ],
      "correct_answer": "C. Apremilast",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Apremilast</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Colchicine: Primarily used for acute gout flares and sometimes for erythema nodosum in Beh\u00e7et's, but not specifically approved for oral ulcers.</li><li>\u2022 Option A. Colchicine:</li><li>\u2022 Option B. Azathioprine: An immunosuppressant used for various autoimmune diseases, but not the first-line treatment for oral ulcers in Beh\u00e7et's.</li><li>\u2022 Option B. Azathioprine:</li><li>\u2022 Option D. Cyclophosphamide: A potent immunosuppressant used for severe manifestations of Beh\u00e7et's (e.g., ocular or neurological involvement), not typically the first choice for isolated oral ulcers.</li><li>\u2022 Option D. Cyclophosphamide:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Apremilast is a relatively new treatment option for managing oral ulcers in Beh\u00e7et syndrome. It offers a targeted approach with a favorable safety profile compared to more traditional immunosuppressive therapies.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7a429204",
      "audio": ""
    },
    {
      "text": "A 25-year-old male presents with a 6-month history of photosensitivity, malar rash, and recurrent episodes of mucositis. He also reports headaches, seizures, and difficulty concentrating. Anti-nuclear antibody (ANA) testing is positive, and anti-dsDNA antibodies are present. A kidney biopsy reveals signs of lupus nephritis. A mutation analysis of which of the following genes is most likely to be informative, regarding the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "TLR7",
          "correct": false
        },
        {
          "label": "B",
          "text": "IRF5",
          "correct": false
        },
        {
          "label": "C",
          "text": "TREX1",
          "correct": true
        },
        {
          "label": "D",
          "text": "TNFSF4",
          "correct": false
        }
      ],
      "correct_answer": "C. TREX1",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) TREX1</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. TLR7: Gain-of-function mutations in TLR7 are associated with SLE, but they typically lead to adult-onset disease with a milder phenotype, not the early-onset and severe neuropsychiatric manifestations seen in this patient.</li><li>\u2022 Option A. TLR7:</li><li>\u2022 Option B. IRF5: Variants in IRF5 increase susceptibility to SLE, but they are not typically associated with monogenic forms or severe neuropsychiatric presentations.</li><li>\u2022 Option B. IRF5:</li><li>\u2022 Option D. TNFSF4: Mutations in TNFSF4 are linked to an increased risk of SLE, but they do not usually cause the specific combination of early-onset, neuropsychiatric symptoms, and lupus nephritis seen in this case.</li><li>\u2022 Option D. TNFSF4:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Monogenic lupus: A small percentage of SLE cases are caused by single gene mutations, with TREX1 being one of the most well-characterized. Patients with monogenic lupus often present with early-onset disease and may have more severe manifestations, including neuropsychiatric involvement. Identifying a TREX1 mutation can confirm the diagnosis of monogenic lupus and has implications for prognosis and treatment.</li><li>\u27a4 Monogenic lupus:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3490e61a",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman presents with pain, swelling, and tenderness in multiple joints, particularly her wrists and knees. She reports morning stiffness lasting about 30 minutes. Physical exam reveals warmth and tenderness in the affected joints, but no obvious deformities. On further question, patient used to experience photosensitive rash usually occurring over the cheeks. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Rheumatoid arthritis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Osteoarthritis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Psoriatic arthritis",
          "correct": false
        },
        {
          "label": "D",
          "text": "SLE-associated polyarthritis",
          "correct": true
        }
      ],
      "correct_answer": "D. SLE-associated polyarthritis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) SLE-associated polyarthritis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Rheumatoid arthritis typically presents with more persistent morning stiffness and may cause joint erosions over time.</li><li>\u2022 Option A. Rheumatoid arthritis</li><li>\u2022 Option B. Osteoarthritis primarily affects weight-bearing joints and is characterized by bony enlargement and crepitus.</li><li>\u2022 Option B. Osteoarthritis</li><li>\u2022 Option C. Psoriatic arthritis is often associated with skin psoriasis and typically involves the distal interphalangeal joints.</li><li>\u2022 Option C. Psoriatic arthritis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 SLE-associated polyarthritis is a common manifestation of systemic lupus erythematosus (SLE), an autoimmune disease. It is important to recognize the clinical presentation of SLE-associated polyarthritis, which can include pain, swelling, and tenderness in multiple joints, along with other systemic symptoms like fatigue, fever, and rash.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "333c07ea",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman presents with a circular, erythematous lesion on her cheek with a raised, scaly border and a depigmented, atrophic center. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Tinea corporis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Psoriasis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Discoid lupus erythematosus (DLE)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Seborrheic dermatitis",
          "correct": false
        }
      ],
      "correct_answer": "C. Discoid lupus erythematosus (DLE)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Discoid lupus erythematosus (DLE)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Tinea corporis (Ringworm): While ringworm can present as a circular lesion, it typically has a more active, inflamed border and central clearing, often with itching. The description of depigmentation and atrophy doesn't fit this diagnosis.</li><li>\u2022 Option A. Tinea corporis (Ringworm):</li><li>\u2022 Option B. Psoriasis: Psoriasis lesions are typically well-demarcated plaques with silvery scales, and they don't usually present with the same degree of central atrophy as seen in DLE.</li><li>\u2022 Option B. Psoriasis:</li><li>\u2022 Option D. Seborrheic dermatitis: This condition presents as greasy, yellowish scales and erythema, usually affecting areas rich in sebaceous glands like the scalp, eyebrows, and nasolabial folds. The depigmentation and atrophy seen in this patient are not characteristic of seborrheic dermatitis.</li><li>\u2022 Option D. Seborrheic dermatitis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the characteristic features of DLE lesions is important for differentiating it from other skin conditions and initiating appropriate treatment.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3b25e7c6",
      "audio": ""
    },
    {
      "text": "What is the approximate percentage of patients with DPGN who either die or develop ESRD within 10 years of diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "5%",
          "correct": false
        },
        {
          "label": "B",
          "text": "10%",
          "correct": false
        },
        {
          "label": "C",
          "text": "20%",
          "correct": true
        },
        {
          "label": "D",
          "text": "50%",
          "correct": false
        }
      ],
      "correct_answer": "C. 20%",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) 20%</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 DPGN is a severe form of lupus nephritis with a poor prognosis. Early recognition and aggressive treatment are essential to improve outcomes.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7cf61710",
      "audio": ""
    },
    {
      "text": "A renal biopsy from a patient with systemic lupus erythematosus (SLE) shows diffuse mesangial hypercellularity with mesangial immune deposits on immunofluorescence. There is no evidence of glomerular crescents or endocapillary proliferation. This finding is consistent with which class of lupus nephritis?",
      "options": [
        {
          "label": "A",
          "text": "Class I",
          "correct": false
        },
        {
          "label": "B",
          "text": "Class II",
          "correct": true
        },
        {
          "label": "C",
          "text": "Class III",
          "correct": false
        },
        {
          "label": "D",
          "text": "Class IV-S(A)",
          "correct": false
        }
      ],
      "correct_answer": "B. Class II",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Class II</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Class I LN has normal glomeruli on light microscopy.</li><li>\u2022 Option A. Class I</li><li>\u2022 Option C. Class III LN involves focal segmental or global lesions.</li><li>\u2022 Option C. Class III</li><li>\u2022 Option D. Class IV-S(A) involves diffuse segmental proliferative lesions.</li><li>\u2022 Option D. Class IV-S(A)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Classifying lupus nephritis is crucial for determining prognosis and guiding treatment decisions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "71345c52",
      "audio": ""
    },
    {
      "text": "A 38-year-old woman with SLE presents with fatigue, dyspnea on exertion, and orthopnea. Physical examination reveals an S3 gallop, jugular venous distension, and bilateral lower extremity edema. Which of the following is the most likely cause of her symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Pericardial effusion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mitral valve regurgitation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pulmonary hypertension",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dilated cardiomyopathy",
          "correct": true
        }
      ],
      "correct_answer": "D. Dilated cardiomyopathy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Dilated cardiomyopathy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Pericardial effusion can cause similar symptoms, but the S3 gallop and bilateral edema are more suggestive of left ventricular dysfunction.</li><li>\u2022 Option A. Pericardial effusion</li><li>\u2022 Option B. Mitral valve regurgitation can also cause heart failure, but it's less common in SLE.</li><li>\u2022 Option B. Mitral valve</li><li>\u2022 regurgitation</li><li>\u2022 Option C. Pulmonary hypertension can cause right heart failure, but the patient's symptoms and signs are more suggestive of left heart failure</li><li>\u2022 Option C. Pulmonary hypertension</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 SLE can affect the heart in various ways, including pericarditis, myocarditis, and valvular disease. Recognizing these cardiac manifestations is essential for early intervention and preventing complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2bcdc030",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman with SLE presents with fatigue, pallor, and jaundice. Laboratory tests reveal anemia, elevated reticulocyte count, and a positive direct Coombs test. Which of the following is the most appropriate initial treatment?",
      "options": [
        {
          "label": "A",
          "text": "Hydroxychloroquine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rituximab",
          "correct": false
        },
        {
          "label": "C",
          "text": "High-dose glucocorticoids",
          "correct": true
        },
        {
          "label": "D",
          "text": "Platelet transfusion",
          "correct": false
        }
      ],
      "correct_answer": "C. High-dose glucocorticoids",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) High-dose glucocorticoids</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hydroxychloroquine is used for SLE management but not as the primary treatment for AIHA.</li><li>\u2022 Option A. Hydroxychloroquine</li><li>\u2022 Option B. Rituximab is a second-line agent for refractory AIHA.</li><li>\u2022 Option B. Rituximab</li><li>\u2022 Option D. Platelet transfusion is not indicated for AIHA unless there is severe thrombocytopenia with bleeding.</li><li>\u2022 Option D. Platelet transfusion</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 AIHA is a common hematologic manifestation of SLE and requires prompt treatment to prevent complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7781fa1d",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman with systemic lupus erythematosus (SLE) presents with edema, fatigue, and foamy urine. Laboratory tests reveal proteinuria of 4.5 g/24 hours, hypoalbuminemia, and hyperlipidemia. What percentage of SLE patients with renal involvement typically develop nephrotic syndrome?",
      "options": [
        {
          "label": "A",
          "text": "5-10%",
          "correct": false
        },
        {
          "label": "B",
          "text": "25%",
          "correct": true
        },
        {
          "label": "C",
          "text": "30-60%",
          "correct": false
        },
        {
          "label": "D",
          "text": "80-90%",
          "correct": false
        }
      ],
      "correct_answer": "B. 25%",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 25%</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. 5-10%: This is the percentage of SLE patients who develop end-stage renal disease, not nephrotic syndrome.</li><li>\u2022 Option A. 5-10%:</li><li>\u2022 Option C. 30-60%: This is the percentage of SLE patients who develop renal involvement (proteinuria and cellular casts), not specifically nephrotic syndrome.</li><li>\u2022 Option C. 30-60%:</li><li>\u2022 Option D. 80-90%: This is an overestimation of the prevalence of nephrotic syndrome in SLE.</li><li>\u2022 Option D. 80-90%:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Renal involvement is common in SLE, and a subset of these patients will develop nephrotic syndrome. Early detection and management are crucial for preventing kidney damage.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0e08d94f",
      "audio": ""
    },
    {
      "text": "A 48-year-old man with a history of SLE for 10 years presents to the emergency department complaining of sudden, painless vision loss in his left eye. He denies any recent trauma, eye pain, redness, or light sensitivity. On examination, his vision is 20/200 in the left eye and normal in the right eye. Funduscopic examination of the left eye reveals cotton wool spots, retinal hemorrhages, and a pale optic disc. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Sicca syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Conjunctivitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Episcleritis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Retinal vasculitis",
          "correct": true
        }
      ],
      "correct_answer": "D. Retinal vasculitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Retinal vasculitis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Sicca syndrome: While common in SLE, it mainly causes dryness, irritation, and blurred vision, not sudden, painless vision loss.</li><li>\u2022 Option A. Sicca syndrome:</li><li>\u2022 Option B. Conjunctivitis: This is inflammation of the conjunctiva (the membrane lining the eyelids and covering the white part of the eye). It usually presents with redness, itching, tearing, and discharge, not sudden vision loss.</li><li>\u2022 Option B. Conjunctivitis:</li><li>\u2022 Option C. Episcleritis: This is inflammation of the episclera (the thin layer of tissue between the conjunctiva and the sclera, the white outer coating of the eye). It typically causes mild redness and discomfort, not sudden vision loss.</li><li>\u2022 Option C. Episcleritis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Retinal vasculitis is a serious complication of SLE and requires urgent evaluation and treatment to preserve vision.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1271c10e",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with a history of systemic lupus erythematosus (SLE) presents to the hospital with acute confusion, disorientation, and new-onset seizures. Brain MRI reveals multiple white matter hyperintensities. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Primary central nervous system (CNS) lymphoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Neuropsychiatric SLE (NPSLE)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Multiple sclerosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cerebral vasculitis",
          "correct": false
        }
      ],
      "correct_answer": "B. Neuropsychiatric SLE (NPSLE)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Neuropsychiatric SLE (NPSLE)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Primary central nervous system ( CNS) lymphoma: While CNS lymphoma can occur in SLE patients, it is less common than NPSLE and typically presents with focal lesions rather than diffuse white matter hyperintensities.</li><li>\u2022 Option A. Primary</li><li>\u2022 central nervous system (</li><li>\u2022 CNS) lymphoma:</li><li>\u2022 Option C. Multiple sclerosis: Multiple sclerosis can also present with white matter lesions on MRI, but the clinical history of SLE and other systemic symptoms makes it less likely in this case.</li><li>\u2022 Option C. Multiple sclerosis:</li><li>\u2022 Option D. Cerebral vasculitis: Cerebral vasculitis is a possible complication of SLE, but it usually presents with focal neurological deficits and less commonly with diffuse cognitive impairment. Additionally, MRI findings in cerebral vasculitis often show ischemic lesions rather than predominantly white matter hyperintensities.</li><li>\u2022 Option D. Cerebral vasculitis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 NPSLE is a common and potentially debilitating manifestation of SLE. Early recognition and treatment are essential to prevent long-term neurological damage.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1c78a83",
      "audio": ""
    },
    {
      "text": "A 37-year-old female presents with a 6-month history of joint pain, photosensitive rash, and intermittent oral ulcers. Laboratory investigations were ordered to assess for autoimmune disorders. An Antinuclear Antibody (ANA) test was performed using indirect immunofluorescence on HEp-2 cells. The result is shown in the image below. Based on the pattern observed, which of the following conditions is most likely associated with this patient's presentation?",
      "options": [
        {
          "label": "A",
          "text": "Systemic Lupus Erythematosus (SLE)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Rheumatoid Arthritis (RA)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Scleroderma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sj\u00f6gren's Syndrome",
          "correct": false
        }
      ],
      "correct_answer": "A. Systemic Lupus Erythematosus (SLE)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/27/screenshot-2024-07-27-162500.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Systemic Lupus Erythematosus (SLE)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Rheumatoid Arthritis (RA): RA may show a positive ANA with different patterns, but the homogeneous pattern is not as strongly associated with RA as it is with SLE.</li><li>\u2022 Option B. Rheumatoid Arthritis (RA):</li><li>\u2022 Option C. Scleroderma: Scleroderma ANA patterns often include nucleolar, centromere, or speckled patterns, not typically homogenous.</li><li>\u2022 Option C. Scleroderma:</li><li>\u2022 Option D. Sj\u00f6gren's Syndrome : Sj\u00f6gren's Syndrome is more commonly associated with a speckled ANA pattern and anti-SSA/Ro and anti-SSB/La antibodies.</li><li>\u2022 Option D. Sj\u00f6gren's Syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the homogeneous pattern in ANA testing is important, as it strongly suggests the possibility of SLE. However, further testing, including specific antibody tests and clinical evaluation, is necessary for a definitive diagnosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "36f0a35f",
      "audio": ""
    },
    {
      "text": "A 36-year-old man is evaluated for symptoms of arthritis, fatigue, and an intermittent rash. Considering his clinical presentation, an Antinuclear Antibody (ANA) test is performed, and the results show a distinct immunofluorescence pattern, shown below. Which autoimmune disease is most closely associated with this ANA pattern?",
      "options": [
        {
          "label": "A",
          "text": "Rheumatoid Arthritis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Systemic Lupus Erythematosus (SLE)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Sj\u00f6gren's Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Systemic Sclerosis (Scleroderma)",
          "correct": false
        }
      ],
      "correct_answer": "B. Systemic Lupus Erythematosus (SLE)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/27/screenshot-2024-07-27-162710.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Systemic Lupus Erythematosus (SLE)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Rheumatoid Arthritis is typically associated with rheumatoid factor and anti-CCP antibodies, not the 'rim' ANA pattern.</li><li>\u2022 Option A. Rheumatoid Arthritis</li><li>\u2022 Option C. Sj\u00f6gren's Syndrome is more commonly associated with anti-Ro/SSA and anti-La/SSB antibodies, which can produce a different ANA pattern.</li><li>\u2022 Option C. Sj\u00f6gren's Syndrome</li><li>\u2022 Option D. Systemic Sclerosis (Scleroderma) often shows ANA patterns such as the nucleolar pattern, not the 'rim' pattern.</li><li>\u2022 Option D. Systemic Sclerosis (Scleroderma)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Identifying the rim pattern in ANA testing is a valuable clue for diagnosing SLE. It signifies the presence of specific autoantibodies targeting dsDNA, a hallmark of the disease. However, it's important to remember that not all SLE patients will exhibit this pattern, and further diagnostic workup is necessary.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "406695f1",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a criterion for defining Lupus Low Disease Activity State (LLDAS)?",
      "options": [
        {
          "label": "A",
          "text": "SLEDAI-2K score \u2264 4",
          "correct": false
        },
        {
          "label": "B",
          "text": "No new lupus disease activity compared to the previous visit",
          "correct": false
        },
        {
          "label": "C",
          "text": "Physician's global assessment \u2264 1 (scale 0-3)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anti-double-stranded DNA antibody titer < 1:80",
          "correct": true
        }
      ],
      "correct_answer": "D. Anti-double-stranded DNA antibody titer < 1:80",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Anti-double-stranded DNA antibody titer < 1:80</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 The other options (A, B, and C) are all essential criteria for LLDAS.</li><li>\u2022 options</li><li>\u2022 (A, B, and C)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 LLDAS is a state of low disease activity in SLE, defined by specific criteria including a SLEDAI-2K score \u2264 4, no new disease activity compared to the previous visit, and a physician's global assessment \u2264 1 (scale 0-3). Understanding these criteria is essential for monitoring disease activity and adjusting treatment plans in SLE patients.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bbb3fe87",
      "audio": ""
    },
    {
      "text": "A 25-year-old woman with severe lupus nephritis is scheduled to begin treatment with high-dose cyclophosphamide. She is concerned about the potential side effects of this medication, particularly the risk of ovarian failure. Which of the following medications can be used to reduce this risk?",
      "options": [
        {
          "label": "A",
          "text": "Methotrexate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Azathioprine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Leuprolide",
          "correct": true
        },
        {
          "label": "D",
          "text": "Belimumab",
          "correct": false
        }
      ],
      "correct_answer": "C. Leuprolide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Leuprolide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 The other option s do not protect against cyclophosphamide-induced ovarian failure.</li><li>\u2022 other option</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Cyclophosphamide is a potent immunosuppressive agent used in severe lupus nephritis, but it can cause premature ovarian failure. Co-administration of leuprolide can mitigate this risk and preserve fertility in young women.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6aa399ad",
      "audio": ""
    },
    {
      "text": "A young woman with SLE presents with new confusion, seizures, and shortness of breath. Exam shows fever, rash, and fluid overload. Labs reveal worsening kidney function and blood counts. Urine analysis suggests nephrotic range proteinuria. Biopsy confirms class IV lupus nephritis. What is the typical initial dose of glucocorticoids?",
      "options": [
        {
          "label": "A",
          "text": "0.1-0.2 mg/kg per day",
          "correct": false
        },
        {
          "label": "B",
          "text": "0.5-1 mg/kg per day",
          "correct": true
        },
        {
          "label": "C",
          "text": "2-3 mg/kg per day",
          "correct": false
        },
        {
          "label": "D",
          "text": "5-10 mg/kg per day",
          "correct": false
        }
      ],
      "correct_answer": "B. 0.5-1 mg/kg per day",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 0.5-1 mg/kg per day</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 High-dose glucocorticoids are the cornerstone of initial therapy for severe SLE manifestations due to their rapid anti-inflammatory and immunosuppressive effects. However, their use should be balanced with the risk of side effects and tapered as soon as possible.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "73433a42",
      "audio": ""
    },
    {
      "text": "A patient with SLE has a renal biopsy showing diffuse proliferative glomerulonephritis (DPGN) classified as ISN/RPS Class IV. Which of the following is the most appropriate induction therapy?",
      "options": [
        {
          "label": "A",
          "text": "Hydroxychloroquine alone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Low-dose prednisone alone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mycophenolate mofetil (MMF) alone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glucocorticoids + cyclophosphamide",
          "correct": true
        }
      ],
      "correct_answer": "D. Glucocorticoids + cyclophosphamide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Glucocorticoids + cyclophosphamide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hydroxychloroquine alone: Hydroxychloroquine is used for milder SLE manifestations.</li><li>\u2022 Option A.</li><li>\u2022 Hydroxychloroquine alone:</li><li>\u2022 Option B. Low-dose prednisone alone: Low-dose prednisone is insufficient for severe nephritis.</li><li>\u2022 Option B.</li><li>\u2022 Low-dose prednisone alone:</li><li>\u2022 Option C. Mycophenolate mofetil (MMF) alone: MMF can be used but is not the standard of care for induction in Class IV LN.</li><li>\u2022 Option C. Mycophenolate mofetil (MMF) alone:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Class IV lupus nephritis is the most severe form of lupus nephritis and requires aggressive induction therapy. The combination of glucocorticoids and cyclophosphamide is the standard of care for induction, followed by maintenance therapy with mycophenolate mofetil or azathioprine.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bbfebab0",
      "audio": ""
    },
    {
      "text": "A 55-year-old Caucasian man presents with fatigue, arthralgia, myalgia, and a low-grade fever. He has been taking hydralazine for hypertension for the past six months. Blood investigations showed Positive ANA. Given the likely diagnosis, which of the following antibodies will be present in this patient, in high titres?",
      "options": [
        {
          "label": "A",
          "text": "Anti-dsDNA antibodies",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti-Smith antibodies",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-Ro/SSA antibodies",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anti-histone antibodies",
          "correct": true
        }
      ],
      "correct_answer": "D. Anti-histone antibodies",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Anti-histone antibodies</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Anti-dsDNA antibodies: These are more specific for systemic lupus erythematosus (SLE) and are less likely to be elevated in DILE.</li><li>\u2022 Option A. Anti-dsDNA antibodies:</li><li>\u2022 Option B. Anti-Smith antibodies: While present in SLE, anti-Smith antibodies are not usually elevated in DILE.</li><li>\u2022 Option B. Anti-Smith antibodies:</li><li>\u2022 Option C. Anti-Ro/SSA antibodies: These antibodies are associated with both SLE and Sj\u00f6gren's syndrome but are not a hallmark of DILE.</li><li>\u2022 Option C. Anti-Ro/SSA antibodies:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the association between anti-histone antibodies and DILE is crucial for accurate diagnosis. This is especially important when a patient presents with lupus-like symptoms while taking a medication known to trigger DILE.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "94e950a2",
      "audio": ""
    },
    {
      "text": "A patient with DILE induced by hydralazine has been successfully treated. Which of the following statements regarding prognosis is most accurate?",
      "options": [
        {
          "label": "A",
          "text": "The patient has a high risk of developing systemic lupus erythematosus (SLE).",
          "correct": false
        },
        {
          "label": "B",
          "text": "The patient is likely to have permanent organ damage.",
          "correct": false
        },
        {
          "label": "C",
          "text": "The patient is expected to have complete resolution of symptoms upon drug withdrawal.",
          "correct": true
        },
        {
          "label": "D",
          "text": "The patient will require lifelong immunosuppressive therapy.",
          "correct": false
        }
      ],
      "correct_answer": "C. The patient is expected to have complete resolution of symptoms upon drug withdrawal.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) The patient is expected to have complete resolution of symptoms upon drug withdrawal.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 The risk of developing SLE is not increased after DILE. Permanent organ damage and lifelong immunosuppression are not usually necessary for DILE.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The prognosis of DILE is generally good, especially with prompt recognition and discontinuation of the offending drug. Patients should be reassured that their symptoms are likely to resolve and long-term complications are rare. However, monitoring for recurrence of symptoms is important if the drug is reintroduced.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0ef360ef",
      "audio": ""
    },
    {
      "text": "A 45-year-old man with a 5-year history of Raynaud's phenomenon presents with progressive skin thickening that is limited to his fingers, hands, and face. He also reports occasional episodes of facial and hand swelling. He offers no other complaints. Physical examination reveals sclerodactyly, telangiectasias on the face, and puffy fingers. Pulmonary function tests and echocardiogram are normal. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Limited cutaneous systemic sclerosis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Diffuse cutaneous systemic sclerosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Scleroderma sine scleroderma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Overlap syndrome",
          "correct": false
        }
      ],
      "correct_answer": "A. Limited cutaneous systemic sclerosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Limited cutaneous systemic sclerosis (lcSSc)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Diffuse cutaneous systemic sclerosis (dcSSc) : This subtype involves skin thickening that extends proximal to the wrists and affects the trunk. Internal organ involvement is more common and occurs earlier in dcSSc compared to lcSSc.</li><li>\u2022 Option B. Diffuse cutaneous systemic sclerosis (dcSSc)</li><li>\u2022 Option C.  Scleroderma sine scleroderma: This rare variant of SSc is characterized by Raynaud's phenomenon and internal organ involvement without significant skin thickening.</li><li>\u2022 Option C.  Scleroderma sine scleroderma:</li><li>\u2022 Option D. Overlap syndrome: This refers to a combination of SSc with features of other connective tissue diseases like polymyositis, dermatomyositis, or systemic lupus erythematosus. There is no evidence of overlap in this case.</li><li>\u2022 Option D. Overlap syndrome:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the distinct clinical features of lcSSc is essential for accurate diagnosis and appropriate management.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6aa4208b",
      "audio": ""
    },
    {
      "text": "Which of the following antibodies is considered an SSc-specific autoantibody?",
      "options": [
        {
          "label": "A",
          "text": "Anti-nuclear antibody (ANA)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti-double stranded DNA (anti-dsDNA) antibody",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-topoisomerase I (Scl-70) antibody",
          "correct": true
        },
        {
          "label": "D",
          "text": "Anti-cyclic citrullinated peptide (anti-CCP) antibody",
          "correct": false
        }
      ],
      "correct_answer": "C. Anti-topoisomerase I (Scl-70) antibody",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Anti-topoisomerase I (Scl-70) antibody</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Anti-nuclear antibody ( ANA) : ANA is not specific to SSc and can be found in other autoimmune diseases.</li><li>\u2022 Option A. Anti-nuclear antibody (</li><li>\u2022 ANA)</li><li>\u2022 :</li><li>\u2022 Option B. Anti-double stranded DNA (anti-dsDNA) antibody : Anti-dsDNA is specific for SLE.</li><li>\u2022 Option B. Anti-double stranded DNA (anti-dsDNA) antibody</li><li>\u2022 Option D. Anti-cyclic citrullinated peptide (anti-CCP) antibody: Anti-CCP is specific for rheumatoid arthritis</li><li>\u2022 Option D. Anti-cyclic citrullinated peptide (anti-CCP) antibody:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Identifying SSc-specific autoantibodies like anti-Scl-70 can aid in diagnosis, subtype classification, and prognostication in patients with suspected SSc.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0ca4646c",
      "audio": ""
    },
    {
      "text": "A 42-year-old woman presents with Raynaud's phenomenon and progressive skin thickening of her hands. Which of the following haplotypes is most strongly associated with an increased risk of systemic sclerosis (SSc)?",
      "options": [
        {
          "label": "A",
          "text": "HLA-DRB104:01",
          "correct": false
        },
        {
          "label": "B",
          "text": "HLA-DRB107:01",
          "correct": false
        },
        {
          "label": "C",
          "text": "HLA-DRB111:04",
          "correct": true
        },
        {
          "label": "D",
          "text": "HLA-DRB115:01",
          "correct": false
        }
      ],
      "correct_answer": "C. HLA-DRB111:04",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) HLA-DRB111:04</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. HLA-DRB104:01 is associated with rheumatoid arthritis.</li><li>\u2022 Option A. HLA-DRB104:01</li><li>\u2022 Option B. HLA-DRB107:01 and Option D. HLA-DRB115:01 have not been consistently linked to SSc.</li><li>\u2022 Option B. HLA-DRB107:01</li><li>\u2022 Option D. HLA-DRB115:01</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understanding the genetic predisposition to SSc can help identify individuals at higher risk and potentially contribute to the development of targeted preventive strategies.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6f6b184d",
      "audio": ""
    },
    {
      "text": "A patient with suspected systemic sclerosis presents with a speckled pattern on antinuclear antibody (ANA) testing. Which autoantibody is most likely associated with this pattern and carries an increased risk of scleroderma renal crisis?",
      "options": [
        {
          "label": "A",
          "text": "Anti-centromere antibody (ACA)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti-topoisomerase I (Scl-70) antibody",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-RNA polymerase III antibody",
          "correct": true
        },
        {
          "label": "D",
          "text": "Anti-U3-RNP (fibrillarin) antibody",
          "correct": false
        }
      ],
      "correct_answer": "C. Anti-RNA polymerase III antibody",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Anti-RNA polymerase III antibody</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option ACA: Centromere pattern, limited SSc, lower renal crisis risk.</li><li>\u2022 Option ACA:</li><li>\u2022 Option Scl-70: Nucleolar/speckled nucleolar pattern, diffuse SSc, lower renal crisis risk.</li><li>\u2022 Option Scl-70:</li><li>\u2022 Option Anti-U3-RNP: Nucleolar pattern, overlap syndromes, less common in SSc, lower renal crisis risk</li><li>\u2022 Option Anti-U3-RNP:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the association between the speckled ANA pattern, anti-RNA polymerase III antibodies, and scleroderma renal crisis is crucial for early detection and prompt intervention to prevent renal failure.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4cb51085",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman presents with a 3-year history of Raynaud's phenomenon and new onset skin tightening of the fingers. Which of the following investigations is MOST helpful in differentiating between primary Raynaud's disease and limited cutaneous systemic sclerosis (lcSSc)?",
      "options": [
        {
          "label": "A",
          "text": "Antinuclear antibody (ANA) test",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary function tests (PFTs)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nailfold capillaroscopy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Echocardiogram",
          "correct": false
        }
      ],
      "correct_answer": "C. Nailfold capillaroscopy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Nailfold capillaroscopy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Antinuclear antibody (ANA) test: ANA testing can be positive in both conditions but is not specific for differentiation.</li><li>\u2022 Option A. Antinuclear antibody (ANA) test:</li><li>\u2022 Option B. Pulmonary function tests ( PFTs) and Option D. Echocardiogram assess for internal organ involvement, which is more common in later stages of SSc and not helpful in early differentiation.</li><li>\u2022 Option B.</li><li>\u2022 Pulmonary function tests (</li><li>\u2022 PFTs)</li><li>\u2022 Option D. Echocardiogram</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Nailfold capillaroscopy is a valuable tool in the early diagnosis of SSc, particularly in patients presenting with Raynaud's phenomenon. It can detect microvascular abnormalities before the onset of significant skin changes or internal organ involvement.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "681a0592",
      "audio": ""
    },
    {
      "text": "Which of the following medications has shown promising results in recent clinical trials for slowing the progression of SSc-associated interstitial lung disease (SSc-ILD)?",
      "options": [
        {
          "label": "A",
          "text": "D-penicillamine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mycophenolate mofetil",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nintedanib",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cyclophosphamide",
          "correct": false
        }
      ],
      "correct_answer": "C. Nintedanib",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Nintedanib</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. D-penicillamine has not shown consistent benefits in recent controlled trials for SSc-ILD.</li><li>\u2022 Option A. D-penicillamine</li><li>\u2022 Option B. Mycophenolate mofetil is often used in SSc, but its primary role is in treating skin and other organ involvement, not specifically ILD.</li><li>\u2022 Option B. Mycophenolate mofetil</li><li>\u2022 Option D. Cyclophosphamide is a potent immunosuppressant used for severe SSc manifestations, but it's not the first-line treatment for ILD.</li><li>\u2022 Option D. Cyclophosphamide</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Nintedanib is an emerging treatment option for SSc-ILD, offering potential hope for patients with this debilitating complication of SSc.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96bd0815",
      "audio": ""
    },
    {
      "text": "Which of the following statements about pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) is TRUE?",
      "options": [
        {
          "label": "A",
          "text": "PAH is a rare complication of SSc.",
          "correct": false
        },
        {
          "label": "B",
          "text": "PAH is typically symptomatic early in its course.",
          "correct": false
        },
        {
          "label": "C",
          "text": "PAH accounts ~30% of deaths in SSc.",
          "correct": true
        },
        {
          "label": "D",
          "text": "The prognosis of PAH in SSc is generally favorable.",
          "correct": false
        }
      ],
      "correct_answer": "C. PAH accounts ~30% of deaths in SSc.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) PAH accounts ~30% of deaths in SSc.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. PAH is a rare complication of SSc: PAH is not rare in SSc; it occurs in a significant minority of patients.</li><li>\u2022 Option A.</li><li>\u2022 PAH is a rare complication of SSc:</li><li>\u2022 Option B. PAH is typically symptomatic early in its course: PAH is often asymptomatic until advanced stages, making early detection crucial.</li><li>\u2022 Option B.</li><li>\u2022 PAH is typically symptomatic early in its course:</li><li>\u2022 Option D. The prognosis of PAH in SSc is generally favorable: The prognosis of PAH in SSc is poor without treatment.</li><li>\u2022 Option D. The prognosis of PAH in SSc is generally favorable:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 PAH is a common and serious complication of SSc. Recognizing the symptoms and initiating appropriate treatment can improve outcomes and prolong survival.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "02d5f47d",
      "audio": ""
    },
    {
      "text": "A patient with scleroderma renal crisis (SRC) is found to have activation of the complement pathway on renal biopsy. Which of the following medications might be considered as an adjunct to ACE inhibitor therapy?",
      "options": [
        {
          "label": "A",
          "text": "Mycophenolate mofetil",
          "correct": false
        },
        {
          "label": "B",
          "text": "Eculizumab",
          "correct": true
        },
        {
          "label": "C",
          "text": "Bosentan",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nintedanib",
          "correct": false
        }
      ],
      "correct_answer": "B. Eculizumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Eculizumab</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The other medications are not specifically targeted towards complement inhibition.</li><li>\u2022 The other medications are not specifically targeted towards complement inhibition.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Eculizumab is a novel therapeutic option for SRC that targets the underlying pathophysiology of the disease. Further research is needed to determine its long-term efficacy and safety in this setting.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "26a9c2e2",
      "audio": ""
    },
    {
      "text": "A 50-year-old woman presents with complaints of dry mouth, dry eyes, and fatigue. On examination, you note enlarged parotid glands and dental caries. Given the likely diagnosis, which of the following is the characteristic histopathological findings?",
      "options": [
        {
          "label": "A",
          "text": "Granulomatous inflammation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Neutrophilic infiltration of exocrine glands",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lymphocytic infiltration of exocrine glands",
          "correct": true
        },
        {
          "label": "D",
          "text": "Deposition of immune complexes in blood vessels",
          "correct": false
        }
      ],
      "correct_answer": "C. Lymphocytic infiltration of exocrine glands",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Lymphocytic infiltration of exocrine glands</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Granulomatous inflammation: Granulomatous inflammation is seen in sarcoidosis.</li><li>\u2022 Option A. Granulomatous inflammation:</li><li>\u2022 Option B. Neutrophilic infiltration of exocrine glands: Neutrophilic infiltration is characteristic of acute infections.</li><li>\u2022 Option B. Neutrophilic infiltration of exocrine glands:</li><li>\u2022 Option D. Deposition of immune complexes in blood vessels: Immune complex deposition is seen in vasculitis .</li><li>\u2022 Option D. Deposition of immune complexes in blood vessels:</li><li>\u2022 .</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Recognizing the characteristic histopathological findings in Sj\u00f6gren's syndrome is crucial for confirming the diagnosis. A lip biopsy is commonly performed to assess the minor salivary glands for lymphocytic infiltration.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "49e68841",
      "audio": ""
    },
    {
      "text": "A 50-year-old female is diagnosed with primary Sj\u00f6gren Syndrome after presenting with dry mouth, difficulty swallowing, and bilateral parotid gland enlargement. Which of the following tests is most specific for diagnosing primary Sj\u00f6gren Syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Rheumatoid factor (RF)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti-nuclear antibody (ANA)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-Ro/SSA and Anti-La/SSB antibodies",
          "correct": true
        },
        {
          "label": "D",
          "text": "Anti-smooth muscle antibody (ASMA)",
          "correct": false
        }
      ],
      "correct_answer": "C. Anti-Ro/SSA and Anti-La/SSB antibodies",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Anti-Ro/SSA and Anti-La/SSB antibodies</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Rheumatoid factor (RF) can be positive in Sj\u00f6gren Syndrome but is not specific as it can be positive in other autoimmune diseases, including rheumatoid arthritis.</li><li>\u2022 Option A. Rheumatoid factor (RF)</li><li>\u2022 Option B. Anti-nuclear antibody (ANA) can be positive in a wide range of autoimmune diseases and is not specific to Sj\u00f6gren Syndrome.</li><li>\u2022 Option B. Anti-nuclear antibody (ANA)</li><li>\u2022 Option D. Anti-smooth muscle antibody (ASMA) is associated with autoimmune hepatitis and not specific for Sj\u00f6gren Syndrome.</li><li>\u2022 Option D. Anti-smooth muscle antibody (ASMA)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 While other tests like RF and ANA can be positive in Sj\u00f6gren's syndrome, they are not as specific as anti-Ro/SSA and anti-La/SSB antibodies. These antibodies, in combination with clinical features, are crucial for establishing the diagnosis of primary Sj\u00f6gren's syndrome.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6d5972ab",
      "audio": ""
    },
    {
      "text": "Which of the following is the MOST common extraglandular manifestation in primary Sj\u00f6gren's syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Fatigue",
          "correct": false
        },
        {
          "label": "B",
          "text": "Arthralgias/Arthritis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Raynaud's phenomenon",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lung involvement",
          "correct": false
        }
      ],
      "correct_answer": "B. Arthralgias/Arthritis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Arthralgias/Arthritis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Fatigue (25%),</li><li>\u2022 Option A.</li><li>\u2022 Fatigue</li><li>\u2022 Option C. Raynaud's phenomenon (37%),</li><li>\u2022 Option C.</li><li>\u2022 Raynaud's phenomenon</li><li>\u2022 Option D. lung involvemen t (14%) are less common.</li><li>\u2022 Option D.</li><li>\u2022 lung involvemen</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the wide range of extraglandular manifestations in Sj\u00f6gren's syndrome is important for comprehensive patient care. While the primary symptoms involve dryness of the eyes and mouth, other organs can be affected, with arthralgias/arthritis being the most prevalent.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "52e4304c",
      "audio": ""
    },
    {
      "text": "A patient with Sj\u00f6gren's syndrome presents with palpable purpura on the lower extremities, arthralgia, and peripheral neuropathy. Which of the following is the most likely underlying pathophysiology?",
      "options": [
        {
          "label": "A",
          "text": "Cryoglobulinemia-associated vasculitis",
          "correct": true
        },
        {
          "label": "B",
          "text": "T-cell mediated cytotoxicity",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-Ro/SSA antibody-mediated damage",
          "correct": false
        },
        {
          "label": "D",
          "text": "Granulomatous inflammation",
          "correct": false
        }
      ],
      "correct_answer": "A. Cryoglobulinemia-associated vasculitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Cryoglobulinemia-associated vasculitis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. T-cell mediated cytotoxicity: T-cell mediated cytotoxicity is involved in other autoimmune diseases but not the primary mechanism in this scenario.</li><li>\u2022 Option B. T-cell mediated cytotoxicity:</li><li>\u2022 Option C. Anti-Ro/SSA antibody-mediated damage : Anti-Ro/SSA antibodies are associated with Sj\u00f6gren's but don't directly cause vasculitis.</li><li>\u2022 Option C. Anti-Ro/SSA antibody-mediated damage</li><li>\u2022 Option D. Granulomatous inflammation: Granulomatous inflammation is more characteristic of conditions like sarcoidosis.</li><li>\u2022 Option D. Granulomatous inflammation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Cryoglobulinemia-associated vasculitis is a serious complication of Sj\u00f6gren's syndrome. Recognizing the associated symptoms and understanding the underlying pathophysiology is crucial for timely diagnosis and appropriate management.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "45760473",
      "audio": ""
    },
    {
      "text": "Which of the following autoantibodies is associated with an increased risk of multiple myeloma in Sj\u00f6gren's syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Anti-dsDNA antibodies",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti-Sm antibodies",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-centromere antibodies",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anti-Ro52 antibodies",
          "correct": true
        }
      ],
      "correct_answer": "D. Anti-Ro52 antibodies",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Anti-Ro52 antibodies</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 While the exact mechanism linking anti-Ro52 antibodies to multiple myeloma is not fully understood, this association highlights the importance of monitoring Sj\u00f6gren's patients with these antibodies for potential hematological malignancies.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "edb08456",
      "audio": ""
    },
    {
      "text": "A 60-year-old man with a history of well-controlled hypertension on medication presents with worsening Raynaud's phenomenon over the past few months. He recently started taking a new medication for migraine prophylaxis. Which medication is most likely to be contributing to his worsening Raynaud's?",
      "options": [
        {
          "label": "A",
          "text": "Calcium channel blocker",
          "correct": false
        },
        {
          "label": "B",
          "text": "Angiotensin-converting enzyme (ACE) inhibitor",
          "correct": false
        },
        {
          "label": "C",
          "text": "Beta blocker",
          "correct": true
        },
        {
          "label": "D",
          "text": "Statin",
          "correct": false
        }
      ],
      "correct_answer": "C. Beta blocker",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Beta blocker</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Calcium channel blockers: These are often used to treat Raynaud's phenomenon because they promote vasodilation and improve blood flow to the extremities.</li><li>\u2022 Option A. Calcium channel blockers:</li><li>\u2022 Option B. Angiotensin-converting enzyme (ACE) inhibitors: These medications can also help improve blood flow, but they are not as commonly used for Raynaud's as calcium channel blockers.</li><li>\u2022 Option B. Angiotensin-converting enzyme (ACE) inhibitors:</li><li>\u2022 Option D. Statins: Statins are used to lower cholesterol and are not known to worsen Raynaud's phenomenon.</li><li>\u2022 Option D. Statins:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 It is crucial to consider the potential impact of medications on Raynaud's phenomenon when managing patients with this condition. Beta blockers should be used with caution or avoided in individuals with Raynaud's, and alternative medications may need to be considered.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bf3b4ff9",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman presents with a 2-year history of episodic color changes in her fingers when exposed to cold temperatures. The episodes start with blanching, followed by cyanosis, and then redness as her fingers rewarm. Physical examination reveals the changes shown in the picture. Which of the following is the most appropriate next step in differentiating primary from secondary raynaud\u2019s?",
      "options": [
        {
          "label": "A",
          "text": "Reassurance and observation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Initiate treatment with nifedipine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Perform nailfold capillaroscopy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Order an antinuclear antibody (ANA) test and rheumatoid factor",
          "correct": false
        }
      ],
      "correct_answer": "C. Perform nailfold capillaroscopy",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/01/screenshot-2024-08-01-170358.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Perform nailfold capillaroscopy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Reassurance and observation: While primary Raynaud's phenomenon is generally benign, it's crucial to rule out secondary causes, especially in patients with new-onset symptoms or those with additional features suggestive of a connective tissue disease.</li><li>\u2022 Option A. Reassurance and observation:</li><li>\u2022 Option B. Initiate treatment with nifedipine: Nifedipine, a calcium channel blocker, can be helpful in managing Raynaud's phenomenon, but it's important to establish the diagnosis first.</li><li>\u2022 Option B. Initiate treatment with nifedipine:</li><li>\u2022 Option D. Order an antinuclear antibody (ANA) test and rheumatoid factor: These tests can help identify underlying autoimmune diseases, but nailfold capillaroscopy is a more specific and sensitive test for differentiating primary and secondary Raynaud's phenomenon.</li><li>\u2022 Option D. Order an antinuclear antibody (ANA) test and rheumatoid factor:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Nailfold capillaroscopy is a valuable diagnostic tool for distinguishing primary and secondary Raynaud's phenomenon. Early differentiation is essential for identifying and managing any underlying connective tissue disease that may be causing the secondary Raynaud's.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3ef9dfa3",
      "audio": ""
    },
    {
      "text": "A patient with Raynaud's phenomenon presents with severe digital ischemia and necrosis of the fingertips. Which of the following medications is most likely to be considered for treatment in this scenario?",
      "options": [
        {
          "label": "A",
          "text": "Nifedipine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Iloprost",
          "correct": true
        },
        {
          "label": "C",
          "text": "Losartan",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sildenafil",
          "correct": false
        }
      ],
      "correct_answer": "B. Iloprost",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Iloprost</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Nifedipine, losartan, and sildenafil are used in milder cases or as preventive measures.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognize that severe Raynaud's phenomenon requires aggressive treatment with potent vasodilators like iloprost to prevent tissue loss and improve outcomes.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bb908c46",
      "audio": ""
    },
    {
      "text": "A 40-year-old man with secondary Raynaud's phenomenon due to systemic sclerosis experiences severe episodes of digital ischemia, leading to fingertip ulcers. His condition has not improved with calcium channel blockers. Which of the following therapeutic options is most appropriate for managing his severe condition?",
      "options": [
        {
          "label": "A",
          "text": "Thermal biofeedback",
          "correct": false
        },
        {
          "label": "B",
          "text": "Endothelin receptor antagonists",
          "correct": true
        },
        {
          "label": "C",
          "text": "Topical nitroglycerin ointment",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cyclophosphamide",
          "correct": false
        }
      ],
      "correct_answer": "B. Endothelin receptor antagonists",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Endothelin receptor antagonists</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Thermal biofeedback: This non-pharmacological therapy can be helpful in mild to moderate Raynaud's, but it is unlikely to be sufficient for severe cases with digital ulcers.</li><li>\u2022 Option A. Thermal biofeedback:</li><li>\u2022 Option C. Topical nitroglycerin ointment: This medication is primarily used to improve local blood flow and may be beneficial in milder cases of Raynaud's, but its efficacy in severe cases with ulcers is limited.</li><li>\u2022 Option C. Topical nitroglycerin ointment:</li><li>\u2022 Option D. Cyclophosphamide: Cyclophosphamide is an immunosuppressant used for severe manifestations of systemic sclerosis, but it is not the first-line treatment for Raynaud's phenomenon.</li><li>\u2022 Option D. Cyclophosphamide:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understand that ERAs are effective in treating severe Raynaud's phenomenon, especially in the context of systemic sclerosis. They target the endothelin pathway, which plays a key role in vasoconstriction and vascular remodelling.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e44b680e",
      "audio": ""
    },
    {
      "text": "A 50-year-old male with a history of alcohol abuse presents with sudden onset of severe pain, redness, and swelling in his left big toe. What is the MOST LIKELY diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Rheumatoid arthritis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gouty arthritis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pseudogout",
          "correct": false
        },
        {
          "label": "D",
          "text": "Osteoarthritis",
          "correct": false
        }
      ],
      "correct_answer": "B. Gouty arthritis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Gouty arthritis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Rheumatoid arthritis : This is an autoimmune condition that typically affects multiple joints symmetrically (both sides of the body). It tends to develop gradually and doesn't usually cause sudden, severe pain in a single joint like gout does.</li><li>\u2022 Option A. Rheumatoid arthritis</li><li>\u2022 Option C. Pseudogout: While similar to gout in terms of causing acute joint pain, pseudogout more commonly affects the knee rather than the big toe. Also, it's not as strongly associated with alcohol use as gout.</li><li>\u2022 Option C.</li><li>\u2022 Pseudogout:</li><li>\u2022 Option D. Osteoarthritis: This is a degenerative joint disease that usually develops slowly over time. It can affect the big toe, but the onset is typically more gradual and less severe than the sudden pain seen in gout.</li><li>\u2022 Option D.</li><li>\u2022 Osteoarthritis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gouty arthritis is a common inflammatory arthritis associated with alcohol use. It typically presents with sudden, severe pain, redness, and swelling in the big toe (podagra). Recognizing the classic presentation and risk factors can help guide appropriate diagnosis and treatment</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "83a1e810",
      "audio": ""
    },
    {
      "text": "A 30-year-old office worker complains of pain and stiffness in the neck and shoulders. She reports feeling exhausted and having trouble sleeping. Physical examination is unremarkable. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Fibromyalgia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Polymyalgia rheumatica",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rheumatoid arthritis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Osteoarthritis",
          "correct": false
        }
      ],
      "correct_answer": "A. Fibromyalgia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Fibromyalgia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Polymyalgia rheumatica (PMR): PMR typically affects older adults (over 50) and causes pain and stiffness in the shoulders and hips. It's also associated with elevated inflammatory markers, which this patient lacks.</li><li>\u2022 Option B. Polymyalgia rheumatica (PMR):</li><li>\u2022 Option C. Rheumatoid arthritis (RA): RA is an autoimmune disease that causes joint inflammation. While it can cause pain and fatigue, it usually affects multiple joints and would likely show up on a physical exam.</li><li>\u2022 Option C. Rheumatoid arthritis (RA):</li><li>\u2022 Option D. Osteoarthritis (OA): OA is a degenerative joint disease that usually affects weight-bearing joints like the knees and hips. While it can affect the neck, it's less common and usually occurs in older individuals with a history of joint wear and tear.</li><li>\u2022 Option D. Osteoarthritis (OA):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Fibromyalgia is a common chronic pain disorder affecting young to middle-aged women. It's characterized by widespread pain, fatigue, sleep disturbances, and cognitive difficulties. The diagnosis is often made based on clinical presentation and the absence of other explanatory conditions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bfc30c47",
      "audio": ""
    },
    {
      "text": "A patient with joint pain undergoes arthrocentesis. The synovial fluid appears clear and forms a long string when expressed from the syringe. Which of the following is the most likely interpretation?",
      "options": [
        {
          "label": "A",
          "text": "Normal synovial fluid",
          "correct": true
        },
        {
          "label": "B",
          "text": "Septic arthritis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gout",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rheumatoid arthritis",
          "correct": false
        }
      ],
      "correct_answer": "A. Normal synovial fluid",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Normal synovial fluid</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Septic arthritis: This is an infection within a joint. The synovial fluid would typically be cloudy or purulent (pus-like) due to the presence of bacteria and white blood cells. It would not form a long string due to decreased viscosity.</li><li>\u2022 Option B. Septic arthritis:</li><li>\u2022 Option C. Gout: Gout is caused by uric acid crystal deposition in the joints. While the synovial fluid can be inflammatory, it is not typically cloudy in the early stages. Urate crystals might be seen under a microscope, but the fluid would not necessarily lose its viscosity.</li><li>\u2022 Option C. Gout:</li><li>\u2022 Option D. Rheumatoid arthritis: This is an autoimmune disease causing chronic joint inflammation. Synovial fluid in rheumatoid arthritis can be cloudy and less viscous, but not always.</li><li>\u2022 Option D. Rheumatoid arthritis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Normal synovial fluid is clear or pale yellow, with normal viscosity, and forms a string when expressed. Abnormal findings can indicate infection, inflammation, or other joint pathology.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "43fc05c2",
      "audio": ""
    },
    {
      "text": "A patient presents with a swollen, painful knee. Synovial fluid analysis reveals a cloudy, yellow fluid with a WBC count of 60,000/\u03bcL and a predominance of neutrophils. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Normal synovial fluid",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gout",
          "correct": false
        },
        {
          "label": "C",
          "text": "Osteoarthritis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Septic arthritis",
          "correct": true
        }
      ],
      "correct_answer": "D. Septic arthritis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Septic arthritis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Normal synovial fluid: Normal synovial fluid is clear or pale yellow, with a low white blood cell (WBC) count (<200/\u00b5L) and few neutrophils.</li><li>\u2022 Option A. Normal synovial fluid:</li><li>\u2022 Option B. Gout: While gout can cause inflammation in the joint, the synovial fluid typically contains urate crystals and a lower WBC count (usually under 50,000/\u00b5L) compared to septic arthritis.</li><li>\u2022 Option B. Gout:</li><li>\u2022 Option C. Osteoarthritis: Osteoarthritis is a degenerative joint disease, and the synovial fluid is usually clear or slightly yellow with a low WBC count and few inflammatory cells.</li><li>\u2022 Option C. Osteoarthritis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Septic arthritis is a joint infection characterized by cloudy, yellow synovial fluid with a high WBC count and predominantly neutrophils. Prompt diagnosis and treatment are crucial to prevent joint damage and complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "018de2c2",
      "audio": ""
    },
    {
      "text": "A 38-year-old woman presents with pain and swelling in multiple joints, including the wrists, hands (predominantly PIP/MTP joints, sparing DIP), and knees. She reports morning stiffness lasting over an hour. Which of the following statements is MOST accurate regarding her condition?",
      "options": [
        {
          "label": "A",
          "text": "Her risk of rheumatoid arthritis (RA) is increased if she has a history of smoking.",
          "correct": true
        },
        {
          "label": "B",
          "text": "Her risk of RA is decreased if she has a family history of autoimmune disease.",
          "correct": false
        },
        {
          "label": "C",
          "text": "RA affects men and women equally.",
          "correct": false
        },
        {
          "label": "D",
          "text": "RA is primarily a disease of the elderly.",
          "correct": false
        }
      ],
      "correct_answer": "A. Her risk of rheumatoid arthritis (RA) is increased if she has a history of smoking.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Her risk of rheumatoid arthritis (RA) is increased if she has a history of smoking.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Her risk of RA is decreased if she has a family history of autoimmune disease: A family history of autoimmune disease actually increases the risk of developing RA.</li><li>\u2022 Option B. Her risk of RA is decreased if she has a family history of autoimmune disease:</li><li>\u2022 Option C. RA affects men and women equally : RA is more common in women than men, with a ratio of approximately 3:1.</li><li>\u2022 Option C. RA affects men and women equally</li><li>\u2022 Option D. RA is primarily a disease of the elderly : While RA can occur at any age, it most commonly begins between the ages of 30 and 60.</li><li>\u2022 Option D. RA is primarily a disease of the elderly</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understanding the risk factors for rheumatoid arthritis (RA) is crucial for identifying individuals at higher risk and potentially implementing preventive measures or early interventions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "86e0270b",
      "audio": ""
    },
    {
      "text": "Which HLA-DRB1 allele is associated with the HIGHEST risk of developing rheumatoid arthritis?",
      "options": [
        {
          "label": "A",
          "text": "*0101",
          "correct": false
        },
        {
          "label": "B",
          "text": "*0404",
          "correct": false
        },
        {
          "label": "C",
          "text": "*0401",
          "correct": true
        },
        {
          "label": "D",
          "text": "*1001",
          "correct": false
        }
      ],
      "correct_answer": "C. *0401",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) *0401</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. *0101 : This is a moderate risk allele, not the highest.</li><li>\u2022 Option A. *0101</li><li>\u2022 Option B. *0404 : This is also a moderate risk allele.</li><li>\u2022 Option B. *0404</li><li>\u2022 Option D. *1001 : Another moderate risk allele</li><li>\u2022 Option D. *1001</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 HLA-DRB1 alleles, particularly *0401, are important genetic risk factors for rheumatoid arthritis. Understanding the role of these alleles in RA development can help with risk assessment and potentially inform personalized treatment approaches in the future.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "09db3126",
      "audio": ""
    },
    {
      "text": "A patient with rheumatoid arthritis (RA) presents with pain and swelling in the distal interphalangeal (DIP) joints of their fingers. Which of the following statements is MOST likely true?",
      "options": [
        {
          "label": "A",
          "text": "DIP joint involvement is a common initial manifestation of RA.",
          "correct": false
        },
        {
          "label": "B",
          "text": "DIP joint involvement is rare in RA and should prompt consideration of other diagnoses.",
          "correct": false
        },
        {
          "label": "C",
          "text": "DIP joint involvement in RA usually indicates coexisting osteoarthritis.",
          "correct": true
        },
        {
          "label": "D",
          "text": "DIP joint involvement in RA typically responds poorly to standard RA treatment.",
          "correct": false
        }
      ],
      "correct_answer": "C. DIP joint involvement in RA usually indicates coexisting osteoarthritis.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) DIP joint involvement in RA usually indicates coexisting osteoarthritis.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. DIP joint involvement is a common initial manifestation of RA: DIP involvement is less common than PIP/MCP in early RA.</li><li>\u2022 Option A.</li><li>\u2022 DIP joint involvement is a common initial manifestation of RA:</li><li>\u2022 Option B. DIP joint involvement is rare in RA and should prompt consideration of other diagnoses: DIP involvement in RA can occur, but suggests possible co-existing osteoarthritis.</li><li>\u2022 Option B. DIP joint involvement is rare in RA and should prompt consideration of other diagnoses:</li><li>\u2022 Option D. DIP joint involvement in RA typically responds poorly to standard RA treatment: RA treatment should help DIP involvement if due to RA.</li><li>\u2022 Option D. DIP joint involvement in RA typically responds poorly to standard RA treatment:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 DIP joint involvement in RA is less common than PIP and MCP joint involvement. It often suggests coexisting osteoarthritis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fa64180f",
      "audio": ""
    },
    {
      "text": "Which of the following is the most common flexor tendon to be affected by rheumatoid arthritis (RA)?",
      "options": [
        {
          "label": "A",
          "text": "Flexor digitorum superficialis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Flexor digitorum profundus",
          "correct": false
        },
        {
          "label": "C",
          "text": "Flexor carpi radialis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Flexor pollicis longus",
          "correct": true
        }
      ],
      "correct_answer": "D. Flexor pollicis longus",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Flexor pollicis longus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Options (A, B, C): While other flexor tendons (flexor digitorum superficialis, flexor digitorum profundus, flexor carpi radialis) can be involved in RA, the FPL is the most frequently affected .</li><li>\u2022 Options (A, B, C):</li><li>\u2022 .</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The flexor pollicis longus tendon is the most commonly affected flexor tendon in RA.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a9e78912",
      "audio": ""
    },
    {
      "text": "Which of the following statements about wrist involvement in RA is FALSE?",
      "options": [
        {
          "label": "A",
          "text": "It often occurs early in the disease course.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It typically involves the radiocarpal and intercarpal joints.",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is always symmetrical.",
          "correct": true
        },
        {
          "label": "D",
          "text": "It can lead to carpal tunnel syndrome.",
          "correct": false
        }
      ],
      "correct_answer": "C. It is always symmetrical.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) It is always symmetrical.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. It often occurs early in the disease course : It often occurs early: True.</li><li>\u2022 Option A. It often occurs early in the disease course</li><li>\u2022 Option B. It typically involves the radiocarpal and intercarpal joints : It typically involves the radiocarpal and intercarpal joints: True.</li><li>\u2022 Option B.</li><li>\u2022 It typically involves the radiocarpal and intercarpal joints</li><li>\u2022 Option D. It can lead to carpal tunnel syndrome: It can lead to carpal tunnel syndrome: True due to synovial inflammation.</li><li>\u2022 Option D. It can lead to carpal tunnel syndrome:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 While wrist involvement is common in RA, it is not always symmetrical, particularly in the early stages of the disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f2692371",
      "audio": ""
    },
    {
      "text": "Which of the following is false regarding extra-articular manifestation of RA?",
      "options": [
        {
          "label": "A",
          "text": "Extra-articular manifestations may develop in 40% of patients.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Extra-articular manifestations will always occur after the onset of arthritis.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Patients most likely to develop extraarticular disease have a history of cigarette smoking.",
          "correct": false
        },
        {
          "label": "D",
          "text": "~10% of patients with RA have secondary Sj\u00f6gren\u2019s syndrome",
          "correct": false
        }
      ],
      "correct_answer": "B. Extra-articular manifestations will always occur after the onset of arthritis.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Extra-articular manifestations will always occur after the onset of arthritis.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Extra-articular manifestations may develop in 40% of patients: This is true.</li><li>\u2022 Option A. Extra-articular manifestations may develop in 40% of patients:</li><li>\u2022 Option C. Patients most likely to develop extraarticular disease have a history of cigarette smoking: This is generally true, as smoking is a known risk factor for both RA and its extra-articular manifestations.</li><li>\u2022 Option C. Patients most likely to develop extraarticular disease have a history of cigarette smoking:</li><li>\u2022 Option D. ~10% of patients with RA have secondary Sj\u00f6gren\u2019s syndrome: This is also true. Secondary Sj\u00f6gren's syndrome is a common extra-articular manifestation of RA, affecting approximately 10% of patients.</li><li>\u2022 Option D. ~10% of patients with RA have secondary Sj\u00f6gren\u2019s syndrome:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 EAMs are common in RA and can affect various organs. Recognizing them is crucial for early diagnosis and appropriate management to prevent complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ebabe80c",
      "audio": ""
    },
    {
      "text": "Which of the following statements is FALSE regarding Felty's syndrome?",
      "options": [
        {
          "label": "A",
          "text": "It is a triad of neutropenia, splenomegaly, and nodular RA.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It typically occurs in the late stages of severe RA.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Its incidence is increasing with more aggressive RA treatment.",
          "correct": true
        },
        {
          "label": "D",
          "text": "It is more common in whites than other racial groups.",
          "correct": false
        }
      ],
      "correct_answer": "C. Its incidence is increasing with more aggressive RA treatment.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Its incidence is increasing with more aggressive RA treatment.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. It is a triad of neutropenia, splenomegaly, and nodular RA: This is the classic definition of Felty's syndrome. Neutropenia is a low count of neutrophils (a type of white blood cell), splenomegaly is an enlarged spleen, and nodular RA refers to the presence of rheumatoid nodules.</li><li>\u2022 Option A. It is a triad of neutropenia, splenomegaly, and nodular RA:</li><li>\u2022 Option B. It typically occurs in the late stages of severe RA: Felty's syndrome is usually seen in patients who have had RA for a long time and whose disease is not well controlled.</li><li>\u2022 Option B. It typically occurs in the late stages of severe RA:</li><li>\u2022 Option D. It is more common in whites than other racial groups: While the exact reason is unknown, studies have shown that Felty's syndrome is more prevalent in white populations.</li><li>\u2022 Option D. It is more common in whites than other racial groups:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Felty's syndrome is a rare but severe complication of RA. Recognizing its classic triad (neutropenia, splenomegaly, nodular RA) is crucial for timely intervention.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ab4a8c77",
      "audio": ""
    },
    {
      "text": "Which of the following statements is TRUE regarding the treatment of Caplan's syndrome?",
      "options": [
        {
          "label": "A",
          "text": "It primarily involves treating the underlying pneumoconiosis.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It requires aggressive immunosuppression to control the lung nodules.",
          "correct": false
        },
        {
          "label": "C",
          "text": "It focuses on managing the rheumatoid arthritis with disease-modifying antirheumatic drugs (DMARDs).",
          "correct": true
        },
        {
          "label": "D",
          "text": "There is no specific treatment for Caplan's syndrome.",
          "correct": false
        }
      ],
      "correct_answer": "C. It focuses on managing the rheumatoid arthritis with disease-modifying antirheumatic drugs (DMARDs).",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) It focuses on managing the rheumatoid arthritis with disease-modifying antirheumatic drugs (DMARDs).</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. It primarily involves treating the underlying pneumoconiosis: Treating pneumoconiosis alone won't address the RA component.</li><li>\u2022 Option A. It primarily involves treating the underlying pneumoconiosis:</li><li>\u2022 Option B. It requires aggressive immunosuppression to control the lung nodules : Aggressive immunosuppression is not typically required.</li><li>\u2022 Option B. It requires aggressive immunosuppression to control the lung nodules</li><li>\u2022 Option D. There is no specific treatment for Caplan's syndrome : There is a specific treatment approach, focused on managing RA.</li><li>\u2022 Option D. There is no specific treatment for Caplan's syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Caplan's syndrome is a rare lung disease occurring in individuals with RA and exposure to dust. Treatment focuses on managing RA to improve both joint and lung outcomes.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c392a6b5",
      "audio": ""
    },
    {
      "text": "What is the most common cause of death in patients with rheumatoid arthritis (RA)?",
      "options": [
        {
          "label": "A",
          "text": "Infectious diseases",
          "correct": false
        },
        {
          "label": "B",
          "text": "Respiratory diseases",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cardiovascular disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cancer",
          "correct": false
        }
      ],
      "correct_answer": "C. Cardiovascular disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Cardiovascular disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Infectious diseases: While RA patients may be at a slightly increased risk of infections due to immunosuppressive treatments, it is not the most common cause of death.</li><li>\u2022 Option A. Infectious diseases:</li><li>\u2022 Option B. Respiratory diseases: Respiratory complications can occur in RA, such as interstitial lung disease, but CVD is still a more significant risk factor.</li><li>\u2022 Option B. Respiratory diseases:</li><li>\u2022 Option D. Cancer: Some studies suggest a slightly elevated cancer risk in RA, but it is not the primary cause of death.</li><li>\u2022 Option D. Cancer:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the increased risk of CVD in RA is essential for implementing preventive strategies like lifestyle modifications and appropriate medication to reduce cardiovascular mortality.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8184d916",
      "audio": ""
    },
    {
      "text": "A patient's hand is shown in the picture below. Which of the following is the MOST LIKELY associated underlying condition?",
      "options": [
        {
          "label": "A",
          "text": "Osteoarthritis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rheumatoid arthritis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Psoriatic arthritis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gout",
          "correct": false
        }
      ],
      "correct_answer": "B. Rheumatoid arthritis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/picture4_3vVtYeA.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Rheumatoid arthritis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Osteoarthritis: Can cause joint deformities, but they typically present as bony enlargements (Heberden's and Bouchard's nodes) rather than the specific swan neck configuration.</li><li>\u2022 Option A.</li><li>\u2022 Osteoarthritis:</li><li>\u2022 Option C. Psoriatic arthritis: Can involve various joints, it doesn't typically cause the swan neck deformity.</li><li>\u2022 Option C.</li><li>\u2022 Psoriatic arthritis:</li><li>\u2022 Option D. Gout: Usually affects the big toe and other joints, causing acute inflammatory attacks, but not the swan neck deformity.</li><li>\u2022 Option D.</li><li>\u2022 Gout:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the swan neck deformity is essential for identifying potential RA in patients presenting with hand deformities. It highlights the importance of a thorough assessment, including history, physical examination, and potentially laboratory and imaging studies, to confirm the diagnosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "be6bf1f5",
      "audio": ""
    },
    {
      "text": "A clinical photograph shows a patient's hand with a visible deformity of the ring finger. There is no sign of trauma, and the patient has a known history of chronic synovitis. Which of the following conditions does this finger deformity represent?",
      "options": [
        {
          "label": "A",
          "text": "Swan neck deformity",
          "correct": false
        },
        {
          "label": "B",
          "text": "Boutonniere deformity",
          "correct": true
        },
        {
          "label": "C",
          "text": "Trigger finger",
          "correct": false
        },
        {
          "label": "D",
          "text": "Jersey finger",
          "correct": false
        }
      ],
      "correct_answer": "B. Boutonniere deformity",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/picture5_xQGW74n.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/picture6_akQEJNQ.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/02/screenshot-2024-08-02-115356.png"
      ],
      "explanation": "<p><strong>Ans. B) Boutonniere deformity</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A . Swan neck deformity: Swan neck deformity is characterized by hyperextension of the PIP joint and flexion of the DIP joint, which is the opposite of the observed deformity.</li><li>\u2022 Option A</li><li>\u2022 Swan neck deformity:</li><li>\u2022 Option C . Trigger finger: Trigger finger involves the locking of a finger in a bent position, typically at the metacarpophalangeal joint, not the PIP joint.</li><li>\u2022 Option C</li><li>\u2022 Trigger finger:</li><li>\u2022 Option D . Jersey finger: Jersey finger is an injury to the flexor tendon of the finger, which usually presents with an inability to flex the DIP joint, contrasting with the hyperextension seen in this patient.</li><li>\u2022 Option D</li><li>\u2022 Jersey finger:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Boutonniere deformity is a common complication of chronic synovitis, often seen in conditions like rheumatoid arthritis. Recognizing this deformity can aid in diagnosing the underlying condition and guide appropriate treatment to prevent further joint damage and functional impairment.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "770171cb",
      "audio": ""
    },
    {
      "text": "Which of the following statements is TRUE regarding rheumatoid factor (RF) in rheumatoid arthritis (RA)?",
      "options": [
        {
          "label": "A",
          "text": "All RA patients have a positive RF test.",
          "correct": false
        },
        {
          "label": "B",
          "text": "A positive RF test is diagnostic for RA.",
          "correct": false
        },
        {
          "label": "C",
          "text": "A negative RF test rules out RA.",
          "correct": false
        },
        {
          "label": "D",
          "text": "RF can be present in both healthy individuals and those with RA.",
          "correct": true
        }
      ],
      "correct_answer": "D. RF can be present in both healthy individuals and those with RA.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) RF can be present in both healthy individuals and those with RA.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. All RA patients have a positive RF test: Not all RA patients have a positive RF test. Some patients have seronegative RA, meaning they test negative for both RF and anti-CCP antibodies.</li><li>\u2022 Option A. All RA patients have a positive RF test:</li><li>\u2022 Option B. A positive RF test is diagnostic for RA: While a positive RF increases the risk of RA, it's not diagnostic on its own. Other conditions can cause elevated RF, and some RA patients are seronegative.</li><li>\u2022 Option B. A positive RF test is diagnostic for RA:</li><li>\u2022 Option C. A negative RF test rules out RA: A negative RF test doesn't necessarily rule out RA. Some patients have seronegative RA.</li><li>\u2022 Option C. A negative RF test rules out RA:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understanding the limitations of RF testing is crucial for accurate RA diagnosis. A positive RF test should be interpreted in conjunction with clinical presentation, other lab tests (like anti-CCP antibodies), and imaging findings.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8506f4aa",
      "audio": ""
    },
    {
      "text": "A patient presents with early morning stiffness and swelling in multiple small joints of the hands. Which of the following imaging modalities is MOST sensitive for detecting early synovitis in suspected rheumatoid arthritis (RA)?",
      "options": [
        {
          "label": "A",
          "text": "Plain radiography (X-ray)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ultrasound",
          "correct": false
        },
        {
          "label": "C",
          "text": "Computed tomography (CT) scan",
          "correct": false
        },
        {
          "label": "D",
          "text": "Magnetic resonance imaging (MRI)",
          "correct": true
        }
      ],
      "correct_answer": "D. Magnetic resonance imaging (MRI)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Magnetic resonance imaging (MRI)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Plain radiography (X-ray): X-rays are insensitive for detecting synovitis, as they primarily image bone and can miss soft tissue inflammation.</li><li>\u2022 Option</li><li>\u2022 A. Plain radiography (X-ray):</li><li>\u2022 Option B. Ultrasound : While ultrasound is a good option for visualizing synovitis, it may not be as sensitive as MRI for detecting very early inflammatory changes, especially in deeper joints.</li><li>\u2022 Option B. Ultrasound</li><li>\u2022 Option C. Computed tomography (CT) scan: CT scans are not routinely used for diagnosing RA due to higher radiation exposure compared to X-ray and MRI. They also may not be as sensitive for detecting synovitis as MRI.</li><li>\u2022 Option C. Computed tomography (CT) scan:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 MRI is the preferred imaging modality for early detection of synovitis in RA. Early diagnosis and intervention are crucial for preventing joint damage and improving long-term outcomes in RA.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fc77b9fe",
      "audio": ""
    },
    {
      "text": "A patient newly diagnosed with rheumatoid arthritis (RA) is prescribed methotrexate. The patient asks when they can expect to see improvement in their symptoms. Which of the following is the most appropriate response?",
      "options": [
        {
          "label": "A",
          "text": "Within a few days",
          "correct": false
        },
        {
          "label": "B",
          "text": "Within 1-2 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "Within 6-12 weeks",
          "correct": true
        },
        {
          "label": "D",
          "text": "Within 6-12 months",
          "correct": false
        }
      ],
      "correct_answer": "C. Within 6-12 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Within 6-12 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Within a few days and Option B. Within 1-2 weeks: These time frames are too short for the onset of DMARDs' action.</li><li>\u2022 Option A. Within a few days</li><li>\u2022 Option B. Within 1-2 weeks:</li><li>\u2022 Option D. Within 6-12 months: This time frames is too long; improvement should be evident sooner</li><li>\u2022 Option D. Within 6-12 months:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Managing patient expectations regarding the onset of action of DMARDs is important for adherence and successful treatment. Patients should be counselled about the delayed onset of action and encouraged to continue therapy even if they don't experience immediate relief.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "106bf87a",
      "audio": ""
    },
    {
      "text": "Which of the following statements regarding chronic low-dose prednisone therapy in rheumatoid arthritis (RA) is TRUE?",
      "options": [
        {
          "label": "A",
          "text": "It should be the first-line treatment for all RA patients.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is not associated with any long-term complications.",
          "correct": false
        },
        {
          "label": "C",
          "text": "It should be avoided whenever possible due to the risk of osteoporosis and other side effects.",
          "correct": true
        },
        {
          "label": "D",
          "text": "It is safe to abruptly discontinue prednisone without tapering.",
          "correct": false
        }
      ],
      "correct_answer": "C. It should be avoided whenever possible due to the risk of osteoporosis and other side effects.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) It should be avoided whenever possible due to the risk of osteoporosis and other side effects.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. It should be the first-line treatment for all RA patients : Prednisone is not a first-line treatment, as other DMARDs are preferred initially.</li><li>\u2022 Option A. It should be the first-line treatment for all RA patients</li><li>\u2022 Option B. It is not associated with any long-term complications : It is associated with numerous long-term complications.</li><li>\u2022 Option B. It is not associated with any long-term complications</li><li>\u2022 Option D. It is safe to abruptly discontinue prednisone without tapering : Abrupt discontinuation can lead to adrenal insufficiency.</li><li>\u2022 Option D. It is safe to abruptly discontinue prednisone without tapering</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 While low-dose prednisone can provide rapid symptomatic relief in RA, its long-term use should be minimized due to potential complications. It is often used as a bridge therapy while waiting for DMARDs to take effect or as an adjunctive treatment for flares.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3c973914",
      "audio": ""
    },
    {
      "text": "A 28-year-old male with early ankylosing spondylitis (AS) and evidence of sacroiliitis on MRI is considering treatment options. Which of the following statements is MOST accurate regarding the potential benefits of early anti-TNF therapy in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Anti-TNF therapy is contraindicated in early AS due to the risk of exacerbating spinal fusion.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Early initiation of anti-TNF therapy may decrease the risk of spinal fusion in the long term.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Anti-TNF therapy should only be considered after spinal fusion has occurred.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anti-TNF therapy has no impact on the progression of spinal fusion in AS.",
          "correct": false
        }
      ],
      "correct_answer": "B. Early initiation of anti-TNF therapy may decrease the risk of spinal fusion in the long term.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Early initiation of anti-TNF therapy may decrease the risk of spinal fusion in the long term.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Anti-TNF therapy is contraindicated in early AS due to the risk of exacerbating spinal fusion : Anti-TNF therapy is not contraindicated; it might actually be beneficial in preventing fusion.</li><li>\u2022 Option A. Anti-TNF therapy is contraindicated in early AS due to the risk of exacerbating spinal fusion</li><li>\u2022 Option C. Anti-TNF therapy should only be considered after spinal fusion has occurred: Early intervention is preferred to prevent irreversible damage.</li><li>\u2022 Option C. Anti-TNF therapy should only be considered after spinal fusion has occurred:</li><li>\u2022 Option D. Anti-TNF therapy has no impact on the progression of spinal fusion in AS: Anti-TNF therapy does have an impact on slowing down structural damage.</li><li>\u2022 Option D. Anti-TNF therapy has no impact on the progression of spinal fusion in AS:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Early intervention with anti-TNF therapy is crucial in AS to prevent irreversible structural damage and maintain spinal flexibility.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "477d53da",
      "audio": ""
    },
    {
      "text": "A 65-year-old male presents with stiffness and mild pain in his thoracic spine. Radiographs reveal flowing ossification along the anterior vertebral bodies, with preserved intervertebral disc spaces. Sacroiliac and facet joints appear normal. Which of the following is the MOST likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Ankylosing spondylitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Osteoarthritis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Diffuse idiopathic skeletal hyperostosis (DISH)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Rheumatoid arthritis",
          "correct": false
        }
      ],
      "correct_answer": "C. Diffuse idiopathic skeletal hyperostosis (DISH)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Diffuse idiopathic skeletal hyperostosis (DISH)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Ankylosing spondylitis : Typically involves sacroiliac joints and can lead to fusion of the spine.</li><li>\u2022 Option A. Ankylosing spondylitis</li><li>\u2022 Option B. Osteoarthritis : Affects the joints primarily, not the ligaments.</li><li>\u2022 Option B. Osteoarthritis</li><li>\u2022 Option D. Rheumatoid arthritis : An inflammatory arthritis that can affect the spine but not in this characteristic pattern.</li><li>\u2022 Option D. Rheumatoid arthritis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 DISH is a common condition in older adults characterized by bony outgrowths in the spine. Recognizing its typical radiographic features is essential for accurate diagnosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2f60b934",
      "audio": ""
    },
    {
      "text": "A patient with AS planned for etanercept therapy, should be screened for which of the following conditions BEFORE initiating treatment?",
      "options": [
        {
          "label": "A",
          "text": "Latent tuberculosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hepatitis B and C",
          "correct": false
        },
        {
          "label": "C",
          "text": "Human Immunodeficiency Virus (HIV)",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) All of the above</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Anti-TNF therapy can reactivate latent infections like TB and worsen hepatitis or HIV, so screening is crucial.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Screening for infections before initiating anti-TNF therapy is crucial for patient safety and preventing complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2f221a38",
      "audio": ""
    },
    {
      "text": "Which of the following statements is TRUE regarding the relationship between psoriasis and psoriatic arthritis (PsA)?",
      "options": [
        {
          "label": "A",
          "text": "All patients with psoriasis will eventually develop PsA.",
          "correct": false
        },
        {
          "label": "B",
          "text": "PsA always develops before the onset of psoriasis.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Up to 30% of patients with psoriasis may develop PsA.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Psoriasis and PsA are caused by different underlying mechanisms.",
          "correct": false
        }
      ],
      "correct_answer": "C. Up to 30% of patients with psoriasis may develop PsA.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Up to 30% of patients with psoriasis may develop PsA.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. All patients with psoriasis will eventually develop PsA: Not all psoriasis patients develop PsA.</li><li>\u2022 Option A. All patients with psoriasis will eventually develop PsA:</li><li>\u2022 Option B. PsA always develops before the onset of psoriasis: PsA can develop before, after, or concurrently with psoriasis.</li><li>\u2022 Option B. PsA always develops before the onset of psoriasis:</li><li>\u2022 Option D. Psoriasis and PsA are caused by different underlying mechanisms : Both conditions share similar underlying inflammatory pathways.</li><li>\u2022 Option D.</li><li>\u2022 Psoriasis and PsA are caused by different underlying mechanisms</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Psoriasis and PsA are linked, but not everyone with psoriasis will develop PsA. Recognizing the potential for PsA is crucial for early diagnosis and intervention to prevent joint damage.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7dac3213",
      "audio": ""
    },
    {
      "text": "A patient with psoriatic arthritis (PsA) is found to have elevated serum levels of RANKL. Which of the following is the most likely consequence of this finding?",
      "options": [
        {
          "label": "A",
          "text": "Decreased bone resorption",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increased bone formation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased osteoclastogenesis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Decreased inflammation",
          "correct": false
        }
      ],
      "correct_answer": "C. Increased osteoclastogenesis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Increased osteoclastogenesis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Decreased bone resorption : RANKL promotes, not decreases, bone resorption.</li><li>\u2022 Option A. Decreased bone resorption</li><li>\u2022 Option B. Increased bone formation : RANKL primarily affects osteoclasts, not osteoblasts.</li><li>\u2022 Option B. Increased bone formation</li><li>\u2022 Option D. Decreased inflammation : RANKL is pro-inflammatory and can exacerbate the inflammatory process.</li><li>\u2022 Option D. Decreased inflammation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 RANKL plays a crucial role in bone remodeling and is implicated in the pathogenesis of PsA. Understanding its role can lead to the development of targeted therapies aimed at inhibiting RANKL to prevent joint damage.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9040c0a3",
      "audio": ""
    },
    {
      "text": "Which of the following statements is TRUE regarding arthritis mutilans in psoriatic arthritis (PsA)?",
      "options": [
        {
          "label": "A",
          "text": "It is a common finding in most PsA patients.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It typically occurs early in the disease course.",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is associated with a good prognosis.",
          "correct": false
        },
        {
          "label": "D",
          "text": "It can lead to significant functional impairment.",
          "correct": true
        }
      ],
      "correct_answer": "D. It can lead to significant functional impairment.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) It can lead to significant functional impairment.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. It is a common finding in most PsA patients: It is a rare and severe form of PsA.</li><li>\u2022 Option A. It is a common finding in most PsA patients:</li><li>\u2022 Option B. It typically occurs early in the disease course: It usually occurs in long-standing, poorly controlled PsA.</li><li>\u2022 Option B. It typically occurs early in the disease course:</li><li>\u2022 Option C. It is associated with a good prognosis: It has a poor prognosis due to its destructive nature.</li><li>\u2022 Option C. It is associated with a good prognosis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Arthritis mutilans is a rare but devastating complication of PsA. Early recognition and aggressive treatment are essential to preserve joint function and quality of life.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fcc3289f",
      "audio": ""
    },
    {
      "text": "Which of the following best describes the structure of infliximab?",
      "options": [
        {
          "label": "A",
          "text": "Fully human monoclonal antibody",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fully mouse monoclonal antibody",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chimeric monoclonal antibody",
          "correct": true
        },
        {
          "label": "D",
          "text": "Humanized monoclonal antibody",
          "correct": false
        }
      ],
      "correct_answer": "C. Chimeric monoclonal antibody",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Chimeric monoclonal antibody</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Fully human monoclonal antibody : These are entirely derived from human sources.</li><li>\u2022 Option A. Fully human monoclonal antibody</li><li>\u2022 Option B. Fully mouse monoclonal antibody : These are entirely derived from mouse sources and can trigger immune reactions in humans.</li><li>\u2022 Option B.</li><li>\u2022 Fully mouse monoclonal antibody</li><li>\u2022 :</li><li>\u2022 Option D. Humanized monoclonal antibody : These have a higher proportion of human components than chimeric antibodies.</li><li>\u2022 Option D.</li><li>\u2022 Humanized monoclonal antibody</li><li>\u2022 :</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understanding the structure of monoclonal antibodies is crucial for comprehending their mechanism of action and potential for adverse effects. Chimeric antibodies offer a balance between efficacy and reduced immunogenicity compared to fully mouse antibodies</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "25fdd314",
      "audio": ""
    },
    {
      "text": "In a direct comparison study for the treatment of PsA, the efficacy of tofacitinib was found to be:",
      "options": [
        {
          "label": "A",
          "text": "Superior to adalimumab",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inferior to adalimumab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Comparable to adalimumab",
          "correct": true
        },
        {
          "label": "D",
          "text": "Not comparable to adalimumab",
          "correct": false
        }
      ],
      "correct_answer": "C. Comparable to adalimumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Comparable to adalimumab</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Options A. Superior to adalimumab & B. Inferior to adalimumab suggest a difference in efficacy, which is not supported by evidence.</li><li>\u2022 Options A. Superior to adalimumab & B. Inferior to adalimumab</li><li>\u2022 Option D . Not comparable to adalimumab suggests no comparison was made, which is incorrect.</li><li>\u2022 Option D</li><li>\u2022 Not comparable to adalimumab</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Both tofacitinib (a Janus kinase inhibitor) and adalimumab (a TNF inhibitor) are effective treatment options for PsA. The choice between them may depend on individual patient factors, comorbidities, and preferences.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "409f0761",
      "audio": ""
    },
    {
      "text": "A 35-year-old male presents with acute onset asymmetric oligoarthritis following a gastrointestinal infection. He is HLA-B27 positive. Synovial fluid analysis is most likely to reveal:",
      "options": [
        {
          "label": "A",
          "text": "Monosodium urate crystals",
          "correct": false
        },
        {
          "label": "B",
          "text": "Calcium pyrophosphate crystals",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aseptic inflammatory pattern",
          "correct": true
        },
        {
          "label": "D",
          "text": "Septic arthritis",
          "correct": false
        }
      ],
      "correct_answer": "C. Aseptic inflammatory pattern",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Aseptic inflammatory pattern</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Monosodium urate crystals are characteristic of gout,</li><li>\u2022 Option A. Monosodium urate crystals</li><li>\u2022 Option B. Calcium pyrophosphate crystals of pseudogout, and</li><li>\u2022 Option B. Calcium pyrophosphate crystals</li><li>\u2022 Option D. Septic arthritis involves infection of the joint.</li><li>\u2022 Option D. Septic arthritis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the typical synovial fluid findings in reactive arthritis helps differentiate it from septic arthritis (where bacteria are present in the joint) and crystal-induced arthritis (where crystals are found in the fluid).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "54cd6d02",
      "audio": ""
    },
    {
      "text": "Which of the following skin manifestations is most specific for reactive arthritis?",
      "options": [
        {
          "label": "A",
          "text": "Psoriasis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Keratoderma blennorrhagica",
          "correct": true
        },
        {
          "label": "C",
          "text": "Erythema nodosum",
          "correct": false
        },
        {
          "label": "D",
          "text": "Erythema multiforme",
          "correct": false
        }
      ],
      "correct_answer": "B. Keratoderma blennorrhagica",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Keratoderma blennorrhagica</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Psoriasis: While psoriasis can occur in patients with ReA, it is not specific to this condition and has a distinct pathophysiology unrelated to ReA.</li><li>\u2022 Option A. Psoriasis:</li><li>\u2022 Option C. Erythema nodosum: Erythema nodosum is a panniculitis (inflammation of subcutaneous fat) that can be triggered by various infections and inflammatory conditions, including ReA. However, it is not specific to ReA.</li><li>\u2022 Option C. Erythema nodosum:</li><li>\u2022 Option D. Erythema multiforme: Erythema multiforme is a hypersensitivity reaction often triggered by infections (e.g., herpes simplex virus) or medications. While it can occasionally occur in the context of ReA, it is not a specific manifestation of this condition.</li><li>\u2022 Option D. Erythema multiforme:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Keratoderma blennorrhagica is a hallmark feature of reactive arthritis and can aid in diagnosis, especially when accompanied by other characteristic symptoms like arthritis, urethritis, and conjunctivitis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1e2df8c5",
      "audio": ""
    },
    {
      "text": "Which of the following is the most appropriate initial treatment for acute reactive arthritis?",
      "options": [
        {
          "label": "A",
          "text": "Methotrexate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sulfasalazine",
          "correct": false
        },
        {
          "label": "C",
          "text": "High-dose NSAIDs",
          "correct": true
        },
        {
          "label": "D",
          "text": "Intra-articular corticosteroids",
          "correct": false
        }
      ],
      "correct_answer": "C. High-dose NSAIDs",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) High-dose NSAIDs</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Methotrexate: Methotrexate is a disease-modifying antirheumatic drug (DMARD) used for chronic inflammatory arthritis like rheumatoid arthritis. It is not typically used as the initial treatment for acute reactive arthritis due to its delayed onset of action and potential side effects.</li><li>\u2022 Option A. Methotrexate:</li><li>\u2022 Option B. Sulfasalazine: Sulfasalazine is another DMARD with anti-inflammatory properties. While it may be considered in cases of persistent ReA that do not respond to NSAIDs, it is not the first-line treatment due to its slower onset of action and potential gastrointestinal side effects.</li><li>\u2022 Option B. Sulfasalazine:</li><li>\u2022 Option D. Intra-articular corticosteroids: These are steroid injections directly into the affected joint. While they can be effective in reducing inflammation and pain in a specific joint, they are not the initial treatment of choice for ReA, as the condition often affects multiple joints and may resolve spontaneously or with NSAIDs.</li><li>\u2022 Option D. Intra-articular corticosteroids:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Prompt initiation of high-dose NSAIDs is crucial for managing acute reactive arthritis and minimizing joint damage. If NSAIDs are ineffective or contraindicated, other options like intra-articular corticosteroids or DMARDs may be considered.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dd7b1746",
      "audio": ""
    },
    {
      "text": "A patient with Crohn's disease presents with acute hip pain and limited range of motion. Radiographs show severe joint space narrowing and osteolysis of the femoral head. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Osteoarthritis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Avascular necrosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Septic arthritis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Isolated destructive hip arthritis",
          "correct": true
        }
      ],
      "correct_answer": "D. Isolated destructive hip arthritis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Isolated destructive hip arthritis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Osteoarthritis (OA): While OA is a common cause of hip pain and joint space narrowing, it typically presents with gradual onset, and radiographs show osteophyte formation (bone spurs) rather than osteolysis (bone destruction). The acute presentation and destructive pattern seen in this patient make OA less likely.</li><li>\u2022 Option A. Osteoarthritis (OA):</li><li>\u2022 Option B. Avascular necrosis (AVN): AVN of the femoral head can also cause hip pain and radiographic changes, but it often presents with a subacute or chronic course. Furthermore, the radiographic findings in AVN usually include sclerosis (increased bone density) and subchondral collapse, which are not as prominent in this case.</li><li>\u2022 Option B. Avascular necrosis (AVN):</li><li>\u2022 Option C. Septic arthritis: Septic arthritis is an infection of the joint that can cause acute pain and joint destruction. However, it is usually accompanied by systemic symptoms like fever and elevated inflammatory markers. Additionally, joint aspiration would reveal purulent fluid with positive cultures, which is not the case here.</li><li>\u2022 Option C. Septic arthritis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 It's important to be aware of isolated destructive hip arthritis as a potential complication in Crohn's disease patients, as it requires prompt recognition and specific management strategies to prevent further joint damage and disability.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a109e731",
      "audio": ""
    },
    {
      "text": "Which of the following skin manifestations is MOST characteristic of SAPHO syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Erythema nodosum",
          "correct": false
        },
        {
          "label": "B",
          "text": "Palmoplantar pustulosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pyoderma gangrenosum",
          "correct": false
        },
        {
          "label": "D",
          "text": "Psoriasis vulgaris",
          "correct": false
        }
      ],
      "correct_answer": "B. Palmoplantar pustulosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Palmoplantar pustulosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 The other options are not typically associated with SAPHO syndrome (syndrome of synovitis, acne, pustulosis, hyperostosis, and osteitis), although they can be seen in other inflammatory conditions.</li><li>\u2022 other options</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing palmoplantar pustulosis as a key feature of SAPHO syndrome can aid in the diagnosis and guide appropriate management of this complex inflammatory disorder.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e9cfa51e",
      "audio": ""
    },
    {
      "text": "A 50-year-old man presents with sudden onset of severe pain and swelling in his right great toe at 3 AM. He has a history of hypertension and hyperlipidemia. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Rheumatoid arthritis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Septic arthritis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pseudogout",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acute gouty arthritis",
          "correct": true
        }
      ],
      "correct_answer": "D. Acute gouty arthritis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Acute gouty arthritis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Rheumatoid arthritis typically presents with symmetric polyarthritis and morning stiffness.</li><li>\u2022 Option A. Rheumatoid arthritis</li><li>\u2022 Option B. Septic arthritis would usually be accompanied by fever and systemic signs of infection.</li><li>\u2022 Option B. Septic arthritis</li><li>\u2022 Option C. Pseudogout can mimic gout but is less likely to involve the great toe.</li><li>\u2022 Option C. Pseudogout</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Acute gouty arthritis is a common inflammatory arthritis characterized by sudden onset severe pain in a single joint, often the great toe. Recognizing the classic presentation and risk factors can help guide appropriate diagnosis and treatment.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "64b60844",
      "audio": ""
    },
    {
      "text": "A patient presents with acute pain and swelling in the knee, and synovial fluid analysis reveals rhomboid-shaped crystals with positive birefringence under polarized light microscopy. Which of the following genetic mutations is most likely associated with this condition?",
      "options": [
        {
          "label": "A",
          "text": "PRPP synthetase mutation",
          "correct": false
        },
        {
          "label": "B",
          "text": "HPRT mutation",
          "correct": false
        },
        {
          "label": "C",
          "text": "ANKH mutation",
          "correct": true
        },
        {
          "label": "D",
          "text": "COL2A1 mutation",
          "correct": false
        }
      ],
      "correct_answer": "C. ANKH mutation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) ANKH mutation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. PRPP synthetase mutation: This mutation is associated with increased uric acid production and is a known cause of gout, not pseudogout. Gout typically presents with needle-shaped crystals with negative birefringence under polarized light microscopy.</li><li>\u2022 Option A. PRPP synthetase mutation:</li><li>\u2022 Option B. HPRT mutation: This mutation leads to Lesch-Nyhan syndrome, a rare genetic disorder characterized by hyperuricemia and neurological symptoms. While Lesch-Nyhan syndrome can cause gout, it's not directly linked to pseudogout or CPPD crystal formation.</li><li>\u2022 Option B. HPRT mutation:</li><li>\u2022 Option D. COL2A1 mutation: This mutation is associated with various skeletal dysplasias, including some types of osteoarthritis. While it can affect joint health, it doesn't directly cause pseudogout or CPPD crystal deposition.</li><li>\u2022 Option D. COL2A1 mutation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understanding the genetic basis of pseudogout is crucial for accurate diagnosis and the development of targeted therapies. Identifying the ANKH mutation in patients with pseudogout can also help assess the risk of familial transmission and guide genetic counseling.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d2933904",
      "audio": ""
    },
    {
      "text": "A patient with a history of gout presents with an acute flare. He is currently taking clarithromycin for a respiratory infection. Which of the following medications should be used with caution in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Indomethacin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prednisone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Colchicine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Celecoxib",
          "correct": false
        }
      ],
      "correct_answer": "C. Colchicine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Colchicine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 The other medications are not significantly affected by CYP3A4 interactions.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Be aware of potential drug interactions when prescribing colchicine, especially with medications that affect CYP3A4 metabolism. Dose adjustments or alternative medications may be necessary to avoid adverse effects.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c7bc3789",
      "audio": ""
    },
    {
      "text": "A patient with recurrent gout flares has failed to achieve target serum urate levels with allopurinol alone. Which of the following is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Increase the dose of allopurinol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Switch to febuxostat",
          "correct": false
        },
        {
          "label": "C",
          "text": "Add probenecid",
          "correct": true
        },
        {
          "label": "D",
          "text": "Consider pegloticase",
          "correct": false
        }
      ],
      "correct_answer": "C. Add probenecid",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Add probenecid</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Increasing allopurinol dose might be an option, but the patient may have already reached the maximum tolerated dose. Switching to febuxostat or considering pegloticase are options for patients who do not tolerate or respond to allopurinol/probenecid combination.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understand the various treatment options for gout and the rationale for combining different medications to achieve target serum urate levels. While increasing the allopurinol dose may be considered, it's important to balance efficacy with potential side effects and consider the maximum tolerated dose. Switching to febuxostat or pegloticase might be considered in patients who don't tolerate or respond to allopurinol/probenecid combination.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "78680319",
      "audio": ""
    },
    {
      "text": "A patient with gout and stage 3 chronic kidney disease tests positive for the HLA-B*5801 allele. Which of the following is the most appropriate urate-lowering therapy for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Allopurinol at a reduced dose",
          "correct": false
        },
        {
          "label": "B",
          "text": "Probenecid",
          "correct": false
        },
        {
          "label": "C",
          "text": "Febuxostat",
          "correct": true
        },
        {
          "label": "D",
          "text": "Colchicine",
          "correct": false
        }
      ],
      "correct_answer": "C. Febuxostat",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Febuxostat</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Allopurinol at a reduced dose: Allopurinol should be avoided in patients with HLA-B*5801 positivity due to the risk of SCARs.</li><li>\u2022 Option A. Allopurinol at a reduced dose:</li><li>\u2022 Option B. Probenecid: Probenecid is not recommended in patients with CKD due to the risk of kidney stones.</li><li>\u2022 Option B. Probenecid:</li><li>\u2022 Option D. Colchicine: Colchicine is not a urate-lowering therapy but is used for acute gout flare management.</li><li>\u2022 Option D. Colchicine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Patients with gout and HLA-B*5801 positivity should be screened before starting allopurinol due to the risk of SCARs. Febuxostat is a safe and effective alternative in these patients, even in the presence of CKD.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "07f294c5",
      "audio": ""
    },
    {
      "text": "What is the pathophysiology behind paradoxical gout flares?",
      "options": [
        {
          "label": "A",
          "text": "Increased production of uric acid",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decreased renal excretion of uric acid",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inflammatory reaction to MSU crystals shed from dissolving tophi",
          "correct": true
        },
        {
          "label": "D",
          "text": "Immune complex formation",
          "correct": false
        }
      ],
      "correct_answer": "C. Inflammatory reaction to MSU crystals shed from dissolving tophi",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Inflammatory reaction to MSU crystals shed from dissolving tophi</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 The other options are not the primary mechanisms behind paradoxical flares.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Paradoxical gout flares are a common complication of ULT initiation. They are usually self-limited and can be managed with prophylactic anti-inflammatory medications. Recognizing this phenomenon can help healthcare providers explain it to patients and ensure proper management during ULT initiation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d7960f33",
      "audio": ""
    },
    {
      "text": "Which of the following genetic polymorphisms is most strongly associated with an increased risk of osteoarthritis (OA)?",
      "options": [
        {
          "label": "A",
          "text": "HLA-B27",
          "correct": false
        },
        {
          "label": "B",
          "text": "GDF5",
          "correct": true
        },
        {
          "label": "C",
          "text": "NOD2",
          "correct": false
        },
        {
          "label": "D",
          "text": "PTPN22",
          "correct": false
        }
      ],
      "correct_answer": "B. GDF5",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) GDF5</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. HLA-B27: This gene is primarily associated with ankylosing spondylitis and other inflammatory conditions, not osteoarthritis.</li><li>\u2022 Option A. HLA-B27:</li><li>\u2022 Option C. NOD2: This gene is associated with Crohn's disease, an inflammatory bowel disease, and not directly linked to osteoarthritis.</li><li>\u2022 Option C. NOD2:</li><li>\u2022 Option D. PTPN22: This gene is associated with autoimmune diseases such as rheumatoid arthritis and type 1 diabetes, but not with osteoarthritis.</li><li>\u2022 Option D. PTPN22:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understanding the genetic factors that contribute to OA susceptibility can help identify individuals at higher risk and potentially lead to the development of personalized prevention and treatment strategies.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "58d46e13",
      "audio": ""
    },
    {
      "text": "The presence of osteophytes in a joint is most indicative of which stage of osteoarthritis?",
      "options": [
        {
          "label": "A",
          "text": "Early OA",
          "correct": false
        },
        {
          "label": "B",
          "text": "Moderate OA",
          "correct": false
        },
        {
          "label": "C",
          "text": "Late OA",
          "correct": true
        },
        {
          "label": "D",
          "text": "Osteophytes are not specific to any stage of OA",
          "correct": false
        }
      ],
      "correct_answer": "C. Late OA",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Late OA</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 While osteophytes may be present in earlier stages, they are more prominent and widespread in late-stage OA.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the radiographic features of OA, such as osteophytes, can help clinicians determine the stage and severity of the disease, which can guide treatment decisions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1d6bb279",
      "audio": ""
    },
    {
      "text": "Which of the following interventions is most likely to result in sustained weight loss and improvement in knee OA symptoms in the long term?",
      "options": [
        {
          "label": "A",
          "text": "A very low-calorie diet for rapid weight loss",
          "correct": false
        },
        {
          "label": "B",
          "text": "A combination of diet, exercise, and behavioral therapy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Over-the-counter weight loss supplements",
          "correct": false
        },
        {
          "label": "D",
          "text": "Liposuction",
          "correct": false
        }
      ],
      "correct_answer": "B. A combination of diet, exercise, and behavioral therapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) A combination of diet, exercise, and behavioral therapy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. A very low-calorie diet for rapid weight loss: Very low-calorie diets are often difficult to sustain and may not be safe for everyone.</li><li>\u2022 Option A. A very low-calorie diet for rapid weight loss:</li><li>\u2022 Option C. Over-the-counter weight loss supplements: Weight loss supplements have limited efficacy and potential side effects.</li><li>\u2022 Option C. Over-the-counter weight loss supplements:</li><li>\u2022 Option D. Liposuction: Liposuction is not a sustainable weight loss solution and does not address the underlying lifestyle factors contributing to OA.</li><li>\u2022 Option D. Liposuction:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Sustainable weight loss and lifestyle modifications are crucial for managing knee OA. A comprehensive approach involving diet, exercise, and behavioral changes is most likely to result in long-term improvement in symptoms and joint health.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ec0b0f07",
      "audio": ""
    },
    {
      "text": "Which of the following is the most common form of bursitis?",
      "options": [
        {
          "label": "A",
          "text": "Olecranon bursitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prepatellar bursitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ischial bursitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Subacromial bursitis",
          "correct": true
        }
      ],
      "correct_answer": "D. Subacromial bursitis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Subacromial bursitis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 The other options represent different types of bursitis that occur in other locations in the body (elbow, knee, and hip, respectively).</li><li>\u2022 other options</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Bursitis is the inflammation of a bursa, a fluid-filled sac that cushions and reduces friction between bones, tendons, and muscles near joints. Subacromial bursitis is the most common type, typically affecting the shoulder due to overuse or injury.</li><li>\u27a4 Bursitis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c065ed74",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman presents with progressive muscle weakness, difficulty swallowing, and a persistent skin rash. She reports feeling tired and experiencing muscle aches. Physical examination reveals erythematous papules and plaques over the knuckles and elbows. Additionally, she has a purplish rash on her eyelids and periorbital edema. On examination patient's hands showing erythematous papules and plaques over the knuckles (as shown in the image below): Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Systemic lupus erythematosus (SLE)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Psoriasis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dermatomyositis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Scleroderma",
          "correct": false
        }
      ],
      "correct_answer": "C. Dermatomyositis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/30/screenshot-2024-07-30-120241.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Dermatomyositis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Systemic lupus erythematosus (SLE): While SLE can present with muscle weakness and skin rash, the pattern of skin involvement and presence of Gottron sign are more characteristic of dermatomyositis.</li><li>\u2022 Option A. Systemic lupus erythematosus (SLE):</li><li>\u2022 Option B. Psoriasis: Psoriasis typically presents with well-demarcated, silvery plaques on extensor surfaces, not the violaceous rash seen in this patient.</li><li>\u2022 Option B. Psoriasis:</li><li>\u2022 Option D. Scleroderma: Scleroderma is characterized by skin thickening and fibrosis, not the muscle weakness and specific rash seen in this case.</li><li>\u2022 Option D. Scleroderma:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognize the key clinical features of dermatomyositis, including Gottron's papules and heliotrope rash, as these are important for early diagnosis and prompt initiation of treatment.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9c5e19c9",
      "audio": ""
    },
    {
      "text": "In adult-onset dermatomyositis, the approximate risk of developing a malignancy within the first 2-3 years is:",
      "options": [
        {
          "label": "A",
          "text": "1%",
          "correct": false
        },
        {
          "label": "B",
          "text": "5%",
          "correct": false
        },
        {
          "label": "C",
          "text": "15%",
          "correct": true
        },
        {
          "label": "D",
          "text": "30%",
          "correct": false
        }
      ],
      "correct_answer": "C. 15%",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) 15%</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. 1% : This underestimates the risk of malignancy in adult-onset dermatomyositis.</li><li>\u2022 Option A. 1%</li><li>\u2022 Option B. 5% : While a significant risk, this is lower than the actual estimated risk.</li><li>\u2022 Option B. 5%</li><li>\u2022 Option D. 30% : This overestimates the risk of malignancy in adult-onset dermatomyositis.</li><li>\u2022 Option D. 30%</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Be aware of the increased risk of malignancy in adult-onset dermatomyositis and consider appropriate screening and surveillance for these patients.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8de78040",
      "audio": ""
    },
    {
      "text": "The predominant inflammatory cell infiltrate in the muscle tissue of dermatomyositis patients is composed of:",
      "options": [
        {
          "label": "A",
          "text": "Neutrophils",
          "correct": false
        },
        {
          "label": "B",
          "text": "Eosinophils",
          "correct": false
        },
        {
          "label": "C",
          "text": "Macrophages, B cells, and plasmacytoid dendritic cells (PDCs)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lymphocytes and plasma cells",
          "correct": false
        }
      ],
      "correct_answer": "C. Macrophages, B cells, and plasmacytoid dendritic cells (PDCs)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Macrophages, B cells, and plasmacytoid dendritic cells (PDCs)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Neutrophils : Not the predominant cell type</li><li>\u2022 Option A. Neutrophils</li><li>\u2022 Option B. Eosinophils : Not the predominant cell type</li><li>\u2022 Option B. Eosinophils</li><li>\u2022 Option D. Lymphocytes and plasma cells : While present, not the most prominent cell types</li><li>\u2022 Option D. Lymphocytes and plasma cells</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understanding the immune cell composition in dermatomyositis can help elucidate the underlying pathophysiology of the disease and guide the development of targeted therapies.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bc05b92c",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT associated with a favorable prognosis in dermatomyositis?",
      "options": [
        {
          "label": "A",
          "text": "Early diagnosis and treatment",
          "correct": false
        },
        {
          "label": "B",
          "text": "Young age",
          "correct": false
        },
        {
          "label": "C",
          "text": "Presence of interstitial lung disease (ILD)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Presence of anti-Mi-2 antibodies",
          "correct": false
        }
      ],
      "correct_answer": "C. Presence of interstitial lung disease (ILD)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Presence of interstitial lung disease (ILD)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Early diagnosis and treatment: Early diagnosis and aggressive treatment can significantly improve outcomes in dermatomyositis.</li><li>\u2022 Option A. Early diagnosis and treatment:</li><li>\u2022 Option B. Young age: Younger patients generally have a better prognosis than older patients.</li><li>\u2022 Option B. Young age:</li><li>\u2022 Option D. Presence of anti-Mi-2 antibodies: The presence of anti-Mi-2 antibodies is often associated with a milder disease course and better response to treatment.</li><li>\u2022 Option D. Presence of anti-Mi-2 antibodies:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the negative impact of ILD on the prognosis of dermatomyositis highlights the importance of early detection and aggressive management of this complication.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4a09eecc",
      "audio": ""
    },
    {
      "text": "Polymyositis (PM) is best characterized by which of the following clinical presentations?",
      "options": [
        {
          "label": "A",
          "text": "Asymmetric distal muscle weakness with rapid progression",
          "correct": false
        },
        {
          "label": "B",
          "text": "Symmetric proximal muscle weakness with gradual progression over weeks to months",
          "correct": true
        },
        {
          "label": "C",
          "text": "Painless muscle atrophy with sensory loss",
          "correct": false
        },
        {
          "label": "D",
          "text": "Focal muscle involvement with cranial nerve palsies",
          "correct": false
        }
      ],
      "correct_answer": "B. Symmetric proximal muscle weakness with gradual progression over weeks to months",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Symmetric proximal muscle weakness with gradual progression over weeks to months</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Asymmetric distal muscle weakness with rapid progression : This is more suggestive of other neuromuscular disorders like Guillain-Barr\u00e9 syndrome.</li><li>\u2022 Option A. Asymmetric distal muscle weakness with rapid progression</li><li>\u2022 Option C. Painless muscle atrophy with sensory loss : This pattern is more indicative of neuropathic conditions.</li><li>\u2022 Option C. Painless muscle atrophy with sensory loss</li><li>\u2022 Option D. Focal muscle involvement with cranial nerve palsies : This might be seen in certain myopathies, but not the typical presentation of polymyositis.</li><li>\u2022 Option D. Focal muscle involvement with cranial nerve palsies</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Recognizing the classic presentation of PM is crucial for timely diagnosis and appropriate management. Distinguishing PM from other neuromuscular disorders with similar symptoms can guide further diagnostic testing and treatment decisions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8a2dcb29",
      "audio": ""
    },
    {
      "text": "A 42-year-old woman presents with progressive muscle weakness, particularly in her thighs and shoulders. She has difficulty climbing stairs and lifting objects. She also reports a persistent cough and shortness of breath on exertion. Additionally, she experiences joint pain and swelling in her hands and knees. Given the likely diagnosis, Which is the most common aminoacyl-tRNA synthetase (ARS) antibody found in this patients?",
      "options": [
        {
          "label": "A",
          "text": "Anti-PL-7",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti-PL-12",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-OJ",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anti-Jo-1",
          "correct": true
        }
      ],
      "correct_answer": "D. Anti-Jo-1",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Anti-Jo-1</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Anti-PL-7, B. Anti-PL-12 and C. Anti-OJ are other ARS antibodies but are less common than anti-Jo-1.</li><li>\u2022 Option A. Anti-PL-7, B. Anti-PL-12</li><li>\u2022 C. Anti-OJ</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the association between anti-Jo-1 antibodies and the clinical triad of myositis, ILD, and arthritis is crucial for accurate diagnosis and management of anti-synthetase syndrome, a subtype of inflammatory myopathy. This syndrome often requires aggressive immunosuppressive therapy to control both the muscle and lung disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f9c504ed",
      "audio": ""
    },
    {
      "text": "In patients with Inclusion Body Myositis (IBM), the average time from symptom onset to requiring a wheelchair or scooter is approximately:",
      "options": [
        {
          "label": "A",
          "text": "5 years",
          "correct": false
        },
        {
          "label": "B",
          "text": "10 years",
          "correct": false
        },
        {
          "label": "C",
          "text": "15 years",
          "correct": true
        },
        {
          "label": "D",
          "text": "20 years",
          "correct": false
        }
      ],
      "correct_answer": "C. 15 years",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) 15 years</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understanding the natural history and progression of IBM is important for patient counselling and planning for future care needs.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b104cb66",
      "audio": ""
    },
    {
      "text": "A 62-year-old man presents with gradual onset of difficulty gripping objects and rising from a chair. He also reports occasional choking when swallowing. Which of the following diagnoses is most likely?",
      "options": [
        {
          "label": "A",
          "text": "Amyotrophic Lateral Sclerosis (ALS)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Polymyositis (PM)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inclusion Body Myositis (IBM)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Myasthenia Gravis",
          "correct": false
        }
      ],
      "correct_answer": "C. Inclusion Body Myositis (IBM)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Inclusion Body Myositis (IBM)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Amyotrophic Lateral Sclerosis (ALS): While ALS can cause muscle weakness, it typically presents with a combination of upper and lower motor neuron signs (e.g., spasticity, hyperreflexia) and does not usually involve dysphagia early in the disease course.</li><li>\u2022 Option A. Amyotrophic Lateral Sclerosis (ALS):</li><li>\u2022 Option B. Polymyositis (PM): PM usually presents with symmetric proximal muscle weakness, rather than the asymmetric pattern of weakness often seen in IBM.</li><li>\u2022 Option B. Polymyositis (PM):</li><li>\u2022 Option D. Myasthenia Gravis: Myasthenia Gravis typically causes fluctuating muscle weakness that worsens with activity and improves with rest. It does not typically cause the pattern of muscle weakness seen in IBM.</li><li>\u2022 Option D. Myasthenia Gravis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the typical clinical presentation of IBM is essential for early diagnosis and appropriate management. IBM can be easily misdiagnosed as other neuromuscular disorders, so a high index of suspicion is necessary.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fd28508a",
      "audio": ""
    },
    {
      "text": "Which of the following staining techniques is most sensitive for detecting inclusions in Inclusion Body Myositis?",
      "options": [
        {
          "label": "A",
          "text": "Congo red stain",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hematoxylin and eosin stain",
          "correct": false
        },
        {
          "label": "C",
          "text": "Periodic acid-Schiff (PAS) stain",
          "correct": false
        },
        {
          "label": "D",
          "text": "Immunostaining for p62",
          "correct": true
        }
      ],
      "correct_answer": "D. Immunostaining for p62",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Immunostaining for p62</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Congo red stain: While Congo red is used to detect amyloid deposits, it is not the most sensitive method for visualizing inclusions in IBM, especially in paraffin-embedded sections. The inclusions in IBM often do not stain well with Congo red due to their specific protein composition.</li><li>\u2022 Option A. Congo red stain:</li><li>\u2022 Option B. Hematoxylin and eosin (H&E) stain: H&E is a standard stain for routine histological examination. It can visualize the general architecture of the muscle tissue and some inclusions, but it lacks the specificity and sensitivity of immunostaining for p62.</li><li>\u2022 Option B. Hematoxylin and eosin (H&E) stain:</li><li>\u2022 Option C. Periodic acid-Schiff (PAS) stain: PAS stain is used to detect glycogen and other carbohydrates. While it can highlight some inclusions in IBM, it is not as specific or sensitive as p62 immunostaining for detecting the beta-sheet misfolded proteins that are characteristic of these inclusions.</li><li>\u2022 Option C. Periodic acid-Schiff (PAS) stain:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Immunostaining for p62 is a valuable diagnostic tool for confirming the presence of characteristic inclusions in IBM muscle biopsies. It is more sensitive and specific than other staining techniques like Congo red, H&E, or PAS.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f2520d65",
      "audio": ""
    },
    {
      "text": "What is the recommended approach for patients with known TPMT deficiency who require azathioprine therapy?",
      "options": [
        {
          "label": "A",
          "text": "Administer the standard dose of azathioprine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Avoid azathioprine completely and use an alternative immunosuppressant",
          "correct": false
        },
        {
          "label": "C",
          "text": "Start azathioprine at a significantly reduced dose",
          "correct": true
        },
        {
          "label": "D",
          "text": "Begin with a standard dose and monitor closely for adverse effects",
          "correct": false
        }
      ],
      "correct_answer": "C. Start azathioprine at a significantly reduced dose",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Start azathioprine at a significantly reduced dose</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 It is crucial to test for TPMT deficiency before initiating azathioprine therapy. If deficiency is detected, the dose must be significantly reduced to avoid serious complications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6f124a81",
      "audio": ""
    },
    {
      "text": "A 58-year-old woman presents with 6 months of progressive proximal muscle weakness, worsened after statin use. Examination reveals no rash. Labs show elevated creatine kinase (CK). Muscle biopsy demonstrates necrotic muscle fibers without significant inflammation. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Polymyositis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dermatomyositis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Necrotizing Autoimmune Myopathy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Myasthenia Gravis",
          "correct": false
        }
      ],
      "correct_answer": "C. Necrotizing Autoimmune Myopathy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Necrotizing Autoimmune Myopathy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Polymyositis: Typically presents with symmetrical proximal weakness but would show inflammatory infiltrates on muscle biopsy.</li><li>\u2022 Option A. Polymyositis:</li><li>\u2022 Option B. Dermatomyositis: Similar to polymyositis but with characteristic skin findings (absent in this case).</li><li>\u2022 Option B. Dermatomyositis:</li><li>\u2022 Option D. Myasthenia Gravis: Presents with fluctuating muscle weakness that worsens with activity and improves with rest. Muscle biopsy would not show necrosis.</li><li>\u2022 Option D. Myasthenia Gravis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Necrotizing autoimmune myopathy (NAM) is a rare subtype of autoimmune myopathies characterized by progressive muscle weakness, elevated creatine kinase, and muscle biopsy showing muscle fiber necrosis with minimal inflammation. Statin use can be a trigger. Treatment involves immunosuppressive medications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f5884807",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with rheumatoid arthritis on corticosteroids for 6 months presents with new-onset proximal muscle weakness and fatigue. Physical examination confirms the muscle weakness. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Systemic lupus erythematosus (SLE)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Polymyalgia rheumatica",
          "correct": false
        },
        {
          "label": "C",
          "text": "Steroid myopathy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hypothyroid myopathy",
          "correct": false
        }
      ],
      "correct_answer": "C. Steroid myopathy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Steroid myopathy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Systemic lupus erythematosus (SLE): While SLE can cause muscle weakness, it is usually accompanied by other systemic symptoms like rash, joint pain, and fever.</li><li>\u2022 Option A. Systemic lupus erythematosus (SLE):</li><li>\u2022 Option B. Polymyalgia rheumatica: Typically affects older individuals and causes pain and stiffness in the shoulders and hips, not weakness.</li><li>\u2022 Option B. Polymyalgia rheumatica:</li><li>\u2022 Option D. Hypothyroid myopathy: Can cause muscle weakness, but it is usually associated with other signs of hypothyroidism, such as fatigue, cold intolerance, and constipation. This patient's symptoms developed after starting corticosteroids, making steroid myopathy more likely.</li><li>\u2022 Option D. Hypothyroid myopathy:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Be aware of the potential for steroid myopathy in patients taking corticosteroids. It is important to monitor for muscle weakness and consider dose reduction or alternative therapies if this side effect develops.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bb928053",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman presents with a 6-month history of widespread pain, fatigue, and difficulty sleeping. She also reports experiencing headaches, irritable bowel syndrome (IBS) symptoms, and anxiety. Physical examination is unremarkable except for multiple tender points. Given her symptoms and physical examination findings, which group of conditions is most likely to include her diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Chronic Fatigue Syndromes",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chronic Overlapping Pain Syndromes",
          "correct": true
        },
        {
          "label": "C",
          "text": "Chronic Regional Pain Syndromes",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chronic Inflammatory Syndromes",
          "correct": false
        }
      ],
      "correct_answer": "B. Chronic Overlapping Pain Syndromes",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Chronic Overlapping Pain Syndromes</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Chronic Fatigue Syndromes: While fatigue is a prominent feature in fibromyalgia, the presence of widespread pain and other symptoms differentiates it from chronic fatigue syndrome, which primarily focuses on debilitating fatigue.</li><li>\u2022 Option A. Chronic Fatigue Syndromes:</li><li>\u2022 Option C. Chronic Regional Pain Syndromes: These syndromes involve pain localized to a specific region of the body, unlike the widespread pain seen in this patient.</li><li>\u2022 Option C. Chronic Regional Pain Syndromes:</li><li>\u2022 Option D. Chronic Inflammatory Syndromes: Although inflammation might play a role in some COPS conditions, it's not the defining characteristic. Fibromyalgia, for example, is not primarily an inflammatory disorder.</li><li>\u2022 Option D. Chronic Inflammatory Syndromes:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Recognizing the concept of COPS is important for understanding the complex interplay of various chronic pain conditions and their potential shared pathophysiological mechanisms. This can help guide a more holistic approach to diagnosis and management.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "22ccae63",
      "audio": ""
    },
    {
      "text": "A 55-year-old man with a history of rheumatoid arthritis presents with proteinuria and peripheral edema. Renal biopsy reveals amyloid deposits. Which type of amyloidosis is most likely in this patient?",
      "options": [
        {
          "label": "A",
          "text": "AA Amyloidosis",
          "correct": true
        },
        {
          "label": "B",
          "text": "AL Amyloidosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "A\u03b2 Amyloidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "ATTR Amyloidosis",
          "correct": false
        }
      ],
      "correct_answer": "A. AA Amyloidosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) AA Amyloidosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. AL Amyloidosis : Associated with plasma cell dyscrasias.</li><li>\u2022 Option B. AL Amyloidosis</li><li>\u2022 Option C. A\u03b2 Amyloidosis : Associated with Alzheimer's disease and deposits in the brain.</li><li>\u2022 Option C. A\u03b2 Amyloidosis</li><li>\u2022 Option D. ATTR Amyloidosis : Primarily affects the heart and nerves.</li><li>\u2022 Option D. ATTR Amyloidosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Recognizing the association between chronic inflammatory diseases and AA amyloidosis is crucial for early diagnosis and intervention to prevent irreversible organ damage.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "aec16002",
      "audio": ""
    },
    {
      "text": "A patient with long-standing multiple myeloma presents with nephrotic syndrome and macroglossia (enlarged tongue). Which of the following types of amyloidosis is most likely?",
      "options": [
        {
          "label": "A",
          "text": "AA Amyloidosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "AL Amyloidosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "A\u03b2 Amyloidosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "ATTR Amyloidosis",
          "correct": false
        }
      ],
      "correct_answer": "B. AL Amyloidosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) AL Amyloidosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. AA Amyloidosis: This type is associated with chronic inflammatory conditions (like rheumatoid arthritis or Crohn's disease) and typically affects the kidneys, liver, and spleen. While it can cause nephrotic syndrome, macroglossia is less common.</li><li>\u2022 Option A. AA Amyloidosis:</li><li>\u2022 Option C. A\u03b2 Amyloidosis: This type is associated with Alzheimer's disease and predominantly affects the brain. It does not typically cause systemic manifestations like nephrotic syndrome or macroglossia.</li><li>\u2022 Option C. A\u03b2 Amyloidosis:</li><li>\u2022 Option D. ATTR Amyloidosis: This type can be hereditary or wild-type (age-related) and primarily affects the heart and nerves. It can also affect the kidneys and gastrointestinal tract, but macroglossia is not a typical feature.</li><li>\u2022 Option D. ATTR Amyloidosis:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Identifying AL amyloidosis as a potential complication of multiple myeloma is essential for prompt diagnosis and treatment to prevent organ damage and improve patient outcomes.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8b95c50b",
      "audio": ""
    },
    {
      "text": "Which diagnostic test is considered the gold standard for confirming the presence of amyloid deposits in tissues?",
      "options": [
        {
          "label": "A",
          "text": "Serum protein electrophoresis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Congo red staining of biopsy tissue",
          "correct": true
        },
        {
          "label": "C",
          "text": "Bone marrow biopsy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Echocardiogram",
          "correct": false
        }
      ],
      "correct_answer": "B. Congo red staining of biopsy tissue",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Congo red staining of biopsy tissue</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Serum protein electrophoresis (SPEP): SPEP can detect abnormal proteins in the blood, which may suggest amyloidosis. However, it does not directly visualize or confirm the presence of amyloid deposits in tissues.</li><li>\u2022 Option A. Serum protein electrophoresis (SPEP):</li><li>\u2022 Option C. Bone marrow biopsy: Bone marrow biopsy is helpful in diagnosing AL amyloidosis, where amyloid deposits originate from light chains produced by plasma cells. However, it's not the gold standard for all types of amyloidosis.</li><li>\u2022 Option C. Bone marrow biopsy:</li><li>\u2022 Option D. Echocardiogram: While an echocardiogram can reveal structural and functional abnormalities in the heart suggestive of amyloidosis (especially ATTR amyloidosis), it does not directly confirm the presence of amyloid deposits. A biopsy is still needed for definitive diagnosis.</li><li>\u2022 Option D. Echocardiogram:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Understanding the role of Congo red staining in the diagnosis of amyloidosis is crucial for accurate identification and classification of this disease. It allows for confirmation of amyloid deposits in various tissues and helps distinguish different types of amyloidosis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "68e1486f",
      "audio": ""
    },
    {
      "text": "A 65-year-old patient with ATTR amyloid cardiomyopathy and New York Heart Association (NYHA) class III heart failure is started on tafamidis. Which of the following is the most realistic expectation of treatment?",
      "options": [
        {
          "label": "A",
          "text": "Complete reversal of heart failure symptoms",
          "correct": false
        },
        {
          "label": "B",
          "text": "Regression of cardiac hypertrophy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stabilization of disease progression and improved quality of life",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cure of the underlying amyloidosis",
          "correct": false
        }
      ],
      "correct_answer": "C. Stabilization of disease progression and improved quality of life",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Stabilization of disease progression and improved quality of life</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Complete reversal of heart failure symptoms: Unlikely due to existing heart damage.</li><li>\u2022 Option A. Complete reversal of heart failure symptoms:</li><li>\u2022 Option B. Regression of cardiac hypertrophy: Tafamidis doesn't reverse thickening.</li><li>\u2022 Option B. Regression of cardiac hypertrophy:</li><li>\u2022 Option B. Regression of cardiac hypertrophy: Tafamidis doesn't reverse thickening.</li><li>\u2022 Option B. Regression of cardiac hypertrophy:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Tafamidis is a valuable therapeutic option for ATTR amyloid cardiomyopathy, but it's important to understand its limitations. It's not a cure but can offer significant benefits in terms of slowing disease progression and improving quality of life.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "29dfb4b3",
      "audio": ""
    }
  ]
}